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ABSTRACT
This dissertation focused on the efficacy and validity of whole genome resequencing
(WGR) for fine mapping genetic determinants of particular traits in a given organism.
Previously, our research group used WGR to identify haplotype blocks of single nucleotide
polymorphisms associated with ascites resistance with some as strong candidates for use in
marker-assisted selection (MAS). Chapter 2 discusses the completion of a MAS project through
evaluation of ascites incidence as well as production traits of economic value to poultry
producers. Thus, the MAS project also covered viability of this methodology in the industry. The
MAS significantly reduced ascites incidence in broilers with no negative impact on bird growth
while some growth characteristics even improved in the MAS genetic line. With the success of
the MAS project and improvements in the bioinformatic pipeline, a new WGR project was
conducted and is discussed in Chapter 3. The goal of the project was to assess whether WGR
could map genetic determinants of resistance to infectious bronchitis virus in white leghorn
chickens. The results of this project revealed a genetic region with strong potential for MAS in
white leghorn chickens which could increase innate resistance in those birds. As a whole, this
work supports the effectiveness of WGR as a powerful tool in the detection of genetic variability
associated with disease resistance.
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CHAPTER 1: LITERATURE REVIEW
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1.1 Chicken as a Food Source and Poultry Breeding
Chicken is a staple in the diets of most people over any other meat type, representing 41% of
meat consumed by humans each year (1). As such, the successful and efficient rearing of
broilers, or meat-type chickens, is paramount to the continued supply of chicken meat. The
consumption of chicken has been relatively steady or increasing for many decades despite
fluctuation in consumption of other meat sources. As of 2020, the average person in the United
States consumes 97.6 pounds of chicken per year (2).
To maintain sufficient supply of high-quality, affordable chicken meat, it is up to the poultry
industry to produce birds that can remain healthy and grow as efficiently as possible. This task
has traditionally been accomplished through the use of bird phenotyping for specific productionrelated traits as the primary driver of selection for many breeding schemes, which is both logical
and useful. In a comparative study by Zuidhof et al. (3), it was found that broilers from 1957 to
2005 have seen a 3.3% increase each year in day 42 body weight and a 50% reduction in feed
conversion ratio at a rate of 2.55% each year. Between those two time points they also found a
30% and 37% increase in tenders weight and 79% and 85% increase in breast weight in males
and females, respectively. In spite of this progress, new problems are given the opportunity to
arise without consideration of the potential genetic relationship between production traits and
other less desirable traits. These include but are not limited to greater fat deposition (4–6),
tendency for eating beyond metabolic requirements (5,7), dampened immune response (8), and
greater overall mortality (9). Issues have also arisen with the musculoskeletal system of the bird.
For example, tibial dyschondroplasia (TD) has been shown to have a moderate to high
heritability but low correlation with body weight (10,11). Since TD is not a direct consequence
of body weight, Hocking (12) posits that the genes leading to susceptibility to TD must have
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been present in broiler founder populations and were linked to the genes that led to highly
efficient growth. As these genes for growth were fixed into early populations of broilers through
phenotypic selection, so were the genes for TD. One issue that can arise directly as a
consequence of rapid growth is a metabolic disorder called ascites around which the work in
Chapter 2 is centered.
In more modern breeding schemes, poultry geneticists have evolved from selection based
solely on bodyweight (BW) to selecting for a number of interconnected factors impacting growth
and bird health (13) (Figure 1-1). This has resulted in a 300-400% improvement in broiler
growth rate over the last 60 years (3,14). The most common breeding scheme utilized today is
the four-way cross, named this way because of the four genetic pools from which the broiler is
produced. Four separate pure pedigree elite lines make up those four genetic pools, two each
denoted as male and female lines. These lines are strictly maintained to ensure the unique genetic
makeup of each. At the point of beginning to produce a broiler, each of the grandparent birds
will come from one of the four unique pedigree elite lines, always using the same gender from
each line. The parent flock called broiler breeders, then, is the product of two of the pedigree
elite line flocks being interbred with the specific male-female flock combination being
maintained each time a broiler-breeder parent flock is produced. Each of these two resulting
broiler-breeder parent flocks are maintained as all-male or all-female and each are a unique
genetic hybrid produced from the pedigree elite lines. Finally, the broiler stock is produced by
crossing the two broiler-breeder flocks, with each resultant bird being a double hybrid (15).
Figure 1-2 is a schematic from Tarrant (16) of this breeding scheme, showing the inverted
pyramid structure that is created through the successive generations.
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1.2 Chicken Genetics
1.2.1 Genome Assemblies
The chicken genome was the first livestock animal to be fully sequenced, with the first draft
of the genome being published in 2004 (17). Hillier et al. accomplished this through several
genomic methods amassing 6.6 coverage of the genome based on the DNA of a single female
from an inbred red jungle fowl line. At the same time, the chromosomal repertoire was
determined to be 38 autosomal chromosomes plus the Z and W sex chromosomes, with
chromosomes 1-10, Z, and W defined as macrochromosomes, 11-16 defined as large
microchromosomes, 17-32 defined as small microchromosomes, and 33-38 defined as the
smallest microchromosomes (18). Micro- and macrochromosomes are debated in the ways that
they differ, but the consistent differences are in size, GC content, gene density, and repetitive
element density (17,19). Subsequent to the first draft genome, more precise genome maps based
on single nucleotide polymorphisms (SNPs), bacterial artificial chromosomes, and fosmids were
produced spanning an estimated 1.09 gigabases (19). The finalized first version of the genome
was released in 2006, denoted Gallus_gallus-2.1 or galGal3 (20). As sequencing methods
progressed, updated assemblies of the genome were produced and released. Rather than only
using Sanger sequencing, next-generation sequencing technology led to the Gallus_gallus-4.0
(galGal4) assembly in 2011 (19,21). Improvements in this assembly over galGal3 included the
removal of approximately 10 megabases of duplicate sequence, an increase in N50 contig
(representing the contiguity of the assembly; 22) and scaffold size, a more than 2-fold increase
each in the size of the Z and W chromosomes, and the addition of 15 megabases of sequence
(19,23). Warren et al. (19) sought to improve upon this assembly through the use of deep
coverage long single molecule sequencing technology. This assembly, termed Gallus_gallus_5.0
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(24), added 183 megabases of sequence including 16.4 megabases added to previously
sequenced chromosomes. This release included sequence from three microchromosomes (30, 31,
and 33) for the first time, and increased the number of annotated genes by more than 4,000.
Finally, GRCg6a (galGal6) (25) was released between 2018 and 2019, showing updated lengths
of chromosomes 16 and 30, fewer unplaced scaffolds, and improved N50 (26). Two versions of
GRCg6a were released: a maternal broiler and a paternal layer.
1.2.2 Single Nucleotide Polymorphisms
Although the majority of the genome is shared between two individuals of a given species,
many small differences exist which account for the phenotypic variation between each
individual. The first of these variations to be detected were restriction fragment length
polymorphism or RFLP (27). Through restriction enzymes isolated from bacteria, a DNA sample
could be digested in order to cleave the DNA at specific target sequences throughout the
genome. Fragment length differences between two samples were identified via gel
electrophoresis followed by Southern blotting. RFLP differences were often based on point
mutations in some of the target sites of the restriction enzyme (28,29). Importantly, RFLP are codominantly inherited and presented the first method for the determination of the parental source
of an allele (30). RFLPs as markers were replaced by variable number tandem repeats (VNTRs),
which are repetitive elements of more than 6 nucleotides repeated in the genome immediately
next to one another and presented the opportunity to identify genetic linkage in families (31,32).
More than half of VNTR sites identified in humans are closely affiliated with genes and
therefore are likely to impact gene expression (33). Problematically at the time, the detection of
RFLP and VNTRs required a large amount of high-quality DNA and Southern blots or
sequencing gels, making the detection of both marker types labor-intensive (34).
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As detection methods progressed, single nucleotide polymorphisms (SNPs) quickly became
the preferred method for mapping genetic variability. SNPs are point mutations found throughout
the genome. Though similar to substitution mutations, they differ in that SNPs must be found in
more than 1% of the population to be classified as such and occur at a much higher frequency
than other polymorphisms making them preferable for the detection of variations associated with
disease (35,36). In 2004, Wong et al. (37) published the first SNP map for the chicken genome,
finding 2.8 million SNPs in total. Comparisons were made between wild (Red Jungle Fowl) and
domestic lines (broiler, layer, or Silkie), between domestic lines (broiler-layer, broiler-Silkie, and
layer-Silkie), and within domestic lines (broiler-broiler, layer-layer, and Silkie-Silkie). The
majority of these comparisons revealed an average rate of 5 SNPs per kilobase, whereas in
broiler-broiler and layer-layer the rate was 4 SNPs per kilobase. This difference was postulated
to be due to the closed breeding population systems utilized to produce broilers. In the time since
the publication of this SNP map, SNPs have become easier to genotype and have been utilized as
a means to recognize alleles that are associated with resistance or susceptibility to a disease
(35,38). Given the abundance and frequency of SNPs in the chicken genome, they function as
excellent targets for marker-assisted selection programs.
1.2.3 Marker-Assisted Selection
Marker-assisted selection (MAS) refers to the process by which highly specific genetic
selections can be made in order to elicit a targeted change in a chosen phenotype. Using SNPs
mapped in regions of influence on the phenotype in question, geneticists can select for traits that
exist in a subset of the existing population so that all individuals in future generations will
express the desired phenotype. Collard et al. (39) explains that the linkage of these markers to
alleles responsible for certain traits allows for their detection and usage in breeding systems.
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MAS is a technique commonly used in modern agricultural breeding systems, especially in
plants. Xu and Crouch (40) provide several rationales for the use of MAS in plant breeding. One
of particular interest is the ability of MAS to allow for “pyramiding” or “gene stacking.” This is
the accumulation of genes from multiple sources that codes for the same trait, commonly used to
increase the tolerance of plants to certain stressors (41). In cereal crops, MAS has been used for
the assessment of the suitability of certain cultivars for propagation, the incorporation of specific
genes into offspring generations, the pyramiding of genes from a specific phenotype, and to
eliminate unpreferred genes early on in the breeding program (39). Other plants on which MAS
has been performed include beans, cassava, cotton, ryegrass, and tomato (42–45). MAS is
especially important in crop breeding for disease resistance. The review by Farokhzadeh and ali
Fakheri (46) discusses specific cases where MAS could or needs to be swiftly implemented to
reduce disease incidence due to the availability of existing quantitative trait loci (QTL) maps for
the particular disease or for the severity of the disease in those crops. These include tan spot in
wheat, late blight in tomato, leaf rust in barley, and white mold in the common bean. There is
also great potential for this type of targeted breeding to increase the success of crops that are
grown under the restrictions to be certified organic, however there is still ongoing debate as to
whether this would be appropriate for organic systems (47).
MAS has also been utilized in livestock, albeit not yet to the same extent as it has in plants.
At this time, a large portion of the literature has been focused on the identification of QTLs
relating to important traits and that could be utilized in livestock. A few of these traits in cattle
include growth characteristics, meat quality, milk production in dairy cattle, reproductive traits,
disease resistance, and temperature tolerance, many of which encompass several other traits that
can be individually studied and utilized for selection (48–53). Common applications of MAS in
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livestock breeding programs include marker-assisted introgression of desired alleles into a breed
where that allele is not commonly found while still maintaining the overall genetic makeup of
the recipient breed or to produce new hybrid populations whose genetic makeup is simply the
most desirable alleles from each cross (45,54). A study by Pedersen et al. found that utilizing
MAS in a dairy breeding scheme allowed for the reduction of inbreeding compared to more
traditional selection methods (55). In swine, the simulated study of MAS utilization by Hayes
and Goddard (56) showed that MAS would not be an economically feasible option for
commercial breeding until markers more closely linked to QTLs were discovered.
More specifically in poultry, MAS has been feasible for a longer time than in other livestock
species due to the more extensive knowledge of the chicken genome. Our understanding of the
chicken genome has only expanded in the years since it was first assembled (17), revealing new
opportunities to successfully complete highly targeted breeding. While selection programs are of
great importance to the industry, the greatest roadblock arises from the multigenic nature of
many traits that need to be addressed by these programs. A complex trait such as ascites
resistance or susceptibility had not yet been successfully addressed by MAS until the completion
of the work discussed in Chapter 2, indicating that ascites and other complex traits may be
headed for dramatic improvements in commercial operations in the coming years.
1.3 Ascites
1.3.1 Etiology
Ascites, or “water belly” as it is sometimes known in the industry is an often-terminal disease
culminating with the filling of the body cavity with fluid and, commonly, heart failure. The most
recent and substantial review of ascites from the standpoints of pathogenesis, physiology,
immunological response, and genetic influences was compiled in 2013 by Wideman et al. (57).
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Ascites is a disease that is driven by metabolic stress. The earliest cause of ascites was
identified to be associated with the rearing of birds at higher elevations, first reported in Bolivia
(58). Higher elevations have decreased atmospheric pressure and therefore decreased partial
pressure of oxygen, causing lower oxygen content per breath taken by the bird and, in turn,
pulmonary arteriole vasoconstriction and pulmonary hypertension (59). After its initial
discovery, ascites was then reported in areas of lower elevation and became more prominent in
the early 1980s which led to our understanding of other sources of metabolic stress leading to
pulmonary hypertension and ascites (60,61). One potential cause is the need of the bird to
thermoregulate in cold temperatures, where the body’s need to maintain homeostasis increases
blood flow and oxygen demand (62). Another critical and significant source of metabolic stress
in poultry is rapid growth. Targeted genetic selection has created a bird that can accrete
impressive amounts of muscle in the shortest amount of time possible; however, this growth is
highly metabolically taxing. In order to sufficiently oxygenate their tissues, birds would need to
see a 100-fold increase in both cardiac output and also pulmonary vasculature in the 8-week
grow-out period utilized in modern broiler operations (63). Unfortunately, with these changes in
muscle deposition capability, the birds have not acquired an increased cardiopulmonary capacity
to supply oxygenated blood to the rapidly growing body. Schmidt et al. (64) found that a
commonly used modern broiler line even experienced a decreased relative heart size after day 14
of growth. Due to this insufficiency, there is very little reserve capacity of the vasculature that is
not actively being utilized under optimal growth conditions, indicating a severe lack of ability to
cope with any given metabolic stressor (65–72). This condition is further exacerbated by the
predisposition of broilers to decreased red blood cell deformability which on its own results in
pulmonary hypertension (73). In order to overcome this ever-increasing metabolic demand,
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blood pressure is decreased by the dilation of the arteries throughout the body, thereby
decreasing the time taken to get oxygen to the tissues but also initiating other physiological
conditions subsequent to arterial hypotension (63). The increased velocity of blood moving
through the pulmonary system leads to the new problem of incomplete gas exchange; blood must
reside in the pulmonary alveoli for an amount of time such that carbon dioxide can be removed
from the blood and replaced with oxygen. When blood pressure, and thereby blood velocity, is
increased in the pulmonary system as a result of decreased arterial blood pressure, the blood does
not spend sufficient time in the alveoli and does not fully exchange gases before sending this
semi-oxygenated blood out to the tissues, a condition known as hypoxemia (74,75). Arterial
hypotension metabolically leads to fluid retention in the kidneys while the liver is deprived of
oxygen and subsequently damaged. In combination with elevated venous pressure, this leads to
the release of the accumulated fluid from the liver surface into and filling the body cavity, thus
resulting in clinical symptom of ascites (63,76,77).
Though the fluid-filled body cavity may be the most recognizable symptom of late-stage
ascites, another key player leading to bird mortality is the heart. This requires an understanding
of the avian cardiovascular anatomy. While the majority of the avian heart is comparable to the
mammalian heart, the valve separating the right atrium and ventricle is different. In mammalian
hearts, the right atrioventricular valve is a tricuspid valve but the avian version is monocuspid,
consisting of a single muscle flap protruding from the wall of the right ventricle (71). Increased
pulmonary arterial pressure has been demonstrated to cause thickening of the wall of the right
ventricle by the addition of sarcomeres, impeding its ability to pump blood as effectively as
normal (78,79). This hypertrophy is the basis for the elevated right ventricle to total ventricle
(RVTV) ratio used as a quantitative metric for ascites development. Additionally, the valve
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separating the right atrium and ventricle is also a part of the right ventricular wall, meaning that
it experiences hypertrophy in the same way as the ventricle, resulting in leakage back into the
right atrium (79). There is also evidence that this valve plays a role in the pump function of the
right ventricle, making its damage a multi-faceted problem for the cardiovascular system of the
bird (80). This insufficient performance of and damage to the right atrioventricular valve causes
a volume overload in the right ventricle by increasing the blood volume in the right atrium that
must be pumped by the ventricle, leading to dilation of that portion of the heart (81,82).
Prolonged pulmonary hypertension compromises the muscle tone of the heart, specifically in the
right ventricle as this is the section of the heart responsible for propelling blood into the
pulmonary system for reoxygenation. Over time, the heart, especially the right ventricle, tend to
show decreased muscle tone (flaccidity) from overexertion (59,83–88). As the hypertension
progresses over time, the right atrioventricular valve fails causing high venous pressure and
hypoxemia which damages the heart and leads to right ventricular failure (79). Additional
changes commonly seen in the hearts of ascitic birds also include enlargement and a rounded
shape to the apex related to right ventricular failure (81). Figure 1-3 shows a flow chart of the
stages of ascites detailing the progression from metabolic stressor to fluid accumulation. After
the exposure to the stressor, thereby increasing oxygen demand inducing physiological hypoxia,
a cascade is initiated which increases cardiac output and overexerts pressure on the wall of the
right ventricle. The right ventricle thickens to overcome the high pressure, rendering the right
atrioventricular valve ineffective, overloading the volume in the right ventricle and leading to
failure of the right heart. Following right ventricular failure, the building pressure in the veins
leads to the liver’s release of fluid into the body cavity (89). While pulmonary hypertension
leading to ascites is a problem needing attention for the sake of the poultry industry, it also has
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clear parallels to human idiopathic pulmonary arterial hypertension (IPAH) which makes it even
more beneficial for us to study and understand this disorder.
1.3.2 Treatments and Mitigation Techniques
Currently, there are several commonly utilized techniques shown to reduce ascites incidence.
Many relate to the nutrition of the bird and are discussed in the reviews by Baghbanzadeh and
Decuypere and by Khajali and Wideman (89,90) including growth rate management, physical
form of the diet, and the supplementation of omega-3 fatty acids, L-carnitine, or antioxidants.
The management of growth rate is a logical way to also manage ascites incidence, given the
previously established tenet that rapid growth is a substantial metabolic stressor leading to
ascites. Feed restriction allows bird growth rate to be strategically slowed, especially during the
first weeks of life when metabolic rates and thereby oxygen demand are extremely high (91–93).
Problematically, this can reduce bird intake of anticoccidial feed additives which increases flock
susceptibility to coccidiosis (89). Another method for managing growth rate is the reduction in
nutrient density of the feed which has been shown to reduce ascites morbidity and mortality as
long as feed energy content is maintained (94). An additional issue arises from the current trend
to reduce overall crude protein content in feed through precise amino acid supplementation as a
method to reduce feed cost. As shown by Behrooj et al. (95), reduced crude protein diets
significantly increased ascites incidence in broilers experiencing another metabolic stressor such
as hypoxia which they concluded to be contributed to reduced plasma nitric oxide as well as
increased hematocrit and elevated RVTV. This is logical, given that physiological conditions of
reduced nitric oxide have been found to lead to hypertension (96). These conclusions mean that
birds predisposed to greater ascites incidence should not be fed the more cost-effective reduced
crude protein diets, further increasing the economic toll on the grower. One final way that
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growth rate can be limited is through the form of feed provided to the bird. Typically, broilers
are provided with a crumble or pellet feed depending on age. Bölükbasi et al. (97) found that
mash feed reduces ascites incidence compared to crumble or pellet forms and only slows birds
from reaching market weight by 1 to 2 days, but it should be noted that this feed form comes
with increased risk of pendulous or blocked crops so that risk must be considered before
implementing this technique to reduce ascites incidence.
Feed additives have also been utilized to reduce ascites incidence. As previously described,
decreased deformability of red blood cells in broilers and exacerbated by hypoxemia contributes
to increased risk of ascites. Omega-3 fatty acids have been found to decrease blood viscosity and
reduce right ventricular hypertrophy in rats and reduce growth rate in broilers, all of which
indicate the potential for their use in feed formulation for genetic lines or growing locations with
higher incidences of ascites (98,99). L-carnitine is vital in the metabolism of fatty acids and is
vital to cardiac muscle which utilizes long-chain fatty acids for energy production (100). It has
therefore been hypothesized that increased supplementation of L-carnitine in the diet may enable
the bird to more effectively handle metabolic stressors that might lead to the development of
ascites and has been shown to improve cardiovascular traits in rats which would be beneficial to
birds facing the onset of ascites symptoms (101,102). Indeed, this has been demonstrated
successfully by Khajali and Khajali (103) who showed that L-carnitine improved
cardiopulmonary function of broilers reared at high altitude and by Yousefi et al. (104) who
found that it reduced ascites mortality in broilers. Finally, antioxidants have been proposed as a
means to reduce the effects of metabolic stress and ascites incidence. Cawthon et al. (105) found
lower levels of certain endogenous antioxidants that would, under normal conditions, combat the
production of reactive oxygen species (ROS) in the mitochondria of ascitic broilers. The
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overproduction of ROS in pulmonary vascular tissues may cause damage which increases
membrane permeability, potentially increasing pulmonary vascular resistance and eventually
ascites incidence (90,106,107). It does appear that single antioxidant supplementation tends to be
ineffective in reducing ascites mortality (108–111), however one study countered these results by
providing an increased concentration of vitamin C and reducing ascites incidence by 65%
compared to the control group (112). Additionally, vitamin E implants may have the potential to
increase resistance to ascites-causing metabolic stressors by increasing protection from ROS
(106). This method could potentially be utilized in flocks or growing locations where higher
ascites incidence is anticipated. Others have found that the supplementation of several
antioxidants does have strong potential to reduce ascites incidence, as Bautista-Ortega and RuizFeria (113) showed that supplementing a combination of arginine, vitamin E, and vitamin C
improved cardiopulmonary function and decreased damage caused by ROS. There is also
promising data from researchers who supplemented both L-carnitine and coenzyme Q10 which
decreased the incidence of pulmonary hypertension (114). The problem with each of these
methods is the associated increase in the cost of feed with their supplementation.
Genetic selection is an excellent option for reducing ascites incidence by increasing innate
resistance in the bird and possibly alleviating the need for any other mitigation techniques.
However, it must be completed in a very targeted manner to avoid costly production losses as the
largest, highest-yielding birds tend to be the most susceptible (15,79,115–117). This means that
using solely phenotypic selection to increase innate resistance will inadvertently select for
decreased yield. A highly specific method of selection is necessary to avoid the economic losses
of phenotypic selection as well as the time wasted to backtrack over years of selection progress,
an option for which is the topic discussed in Chapter 2.
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1.3.3 Impacts of Ascites
As ascites causes both bird death prior to the time of processing and bird condemnations at
the processing plant, it has impacts on mortality as well as economic impacts. Older statistics
show that ascites has been the cause of 8% or more of bird mortality and had an economic
impact of $100 million annually (118,119). One specific reason for greater losses from ascites is
based on its progressive development in the bird over the course of days or weeks; this means
that more feed and bird care labor have been invested in birds that eventually succumb to
complications from ascites and the company loses the money invested with the death of the bird
(15). However, it should be noted that these estimates are based on data nearing two to three
decades old and updated evaluations of the impacts of ascites are warranted as ascites has been
reduced in lower elevation regions through the efforts of genetics companies to cull out
individuals from pedigree lines who are found by pulse oximetry to be hypoxemic (70,71).
1.3.4 Induction Methods
In order to effectively study ascites, researchers must be able to consistently and concisely
induce the disease. Currently, there are five models most commonly used to accomplish this: salt
inclusion in the feed or drinking water, arterial occlusion, micro-particle injection, cold stress,
and hypoxia by hypobaric challenge.
The salt induction model utilizes the addition of sodium chloride in the feed or drinking
water supplied to the birds. Salt individually is not the culprit, but rather the sodium ion portion
of the molecule. Julian (78) posited that high levels of sodium compounds several mechanisms to
eventually cause ascites. One of these mechanisms is an increase of sodium in the body causing
fluid retention, which in turn increases blood volume known as hypervolemia which then lends
to the damage of the right heart. Relatedly, high dietary sodium incites pulmonary hypertension,
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increases hydraulic pressure in the blood vessels, increases red blood cell rigidity, and causes
right ventricular dilation and hypertrophy (73,81,120). However, it should be noted that this
method tends to yield lower ascites incidence than other induction methods; higher salt
concentrations would likely increase ascites incidence but would also be lethal, especially in
young broilers (121).
The arterial occlusion method is the most invasive method used to induce ascites, as it
requires the surgical clamping of the left pulmonary artery. This is completed by opening the left
thoracic air sac during the surgery and physically clamping the artery, thereby reducing blood
flow to one lung (57). Wideman et al. (122) found that the increased venous pressure caused by
an even seemingly minor applied pressure through unilateral arterial occlusion led to substantial
venous resistance to flow which is one of the two mechanisms responsible for the fluid released
from the surface of the liver (63). This induction method, however, runs the risk of health
complications for the bird post-surgery.
Another ascites induction model involves the injection of cellulose microparticles. This
method has seen such success that it has been patented (US patent no. 6,720,473) for use in the
industry as a diagnostic tool for susceptibility in broiler populations. The microparticles are
suspended in saline with heparin to prevent catastrophic development of pulmonary blood clots
(123). They are circulated until they reach the pulmonary precapillary arterioles where they
become lodged and impede blood flow, inducing pulmonary hypertension (124). Wideman and
Erf used intravenous injections of microparticles into one wing and one leg vein for systemic and
renal portal injection, respectively, which led to responses including pulmonary hypertension and
systemic hypoxemia similar to the responses seen in the arterial occlusion method. Wideman et
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al. (123) found that this microparticle injection method elicits sufficient results to serve as a
viable replacement for the unilateral arterial occlusion method.
Cold stress is a model that most directly replicates one of the growing environments where
birds are likely to develop ascites. Due to the metabolic needs of the body during a cold stress
response, blood pressure is increased, surplus red blood cells are produced to increase oxygencarrying capacity and consequently increases blood viscosity, and ascites ensues (115). The
increased metabolic rate and greater oxygen demand occurs in order to maintain body
temperature when exposed to cold environments (125,126). Pakdel et al. (127) utilized this
model to examine the impact on ascites incidence in broilers. Both the control and experimental
groups were reared under standard commercial conditions aside from the temperature gradient
throughout the experimental period. While the control group experienced a temperature gradient
starting from 34oC on day of hatch and was incrementally reduced to 17oC by day 35, the
experimental group started from 30oC on day of hatch, incrementally reduced to 10oC by day 22,
and maintained at 10oC through day 35. The results from the cold stress group showed an
average body weight reduction of over 400 grams, a 25% increase in hematocrit not
contributable to natural physiological differences due to the age, a 35% increase in RVTV, and
16% ascites mortality while there was no ascites mortality in the control group.
All ascites induction for this dissertation research utilized the hypobaric challenge model
through use of the hypobaric chamber at the University of Arkansas Poultry Research Farm. This
method allows for birds to be placed in battery cages in a simulated high-elevation environment,
accomplished by reducing the pressure in the chamber and therefore the partial pressure of
oxygen. This induction method is reliable, non-invasive, and efficiently induces ascites
regardless of genetic line or other factors and has been extensively utilized in ascites research
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(63). Further, the hypobaric effect can be exacerbated by providing chick feed formulated for
rapid growth for the duration of the trial.
1.4 Foundational Ascites Work
Ascites research lines have been developed at the University of Arkansas. Pavlidis et al.
(128) used sibling selection in a commercial elite line to create three sublines: ascites susceptible
(SUS), ascites resistant (RES), and a randomly mated subline to represent the founder population
(Relaxed, REL). Sibling selection is the process of assessing the phenotype of one group of
birds, and then using that data to select siblings of the phenotyped birds to be used for producing
the next generation. Specifically, birds were reared in the hypobaric chamber at simulated 9,500
feet elevation while the siblings were reared in a similar chamber at the ambient pressure of
northwest Arkansas, approximately 1,500 feet. Ascites phenotype data was collected throughout
the trial. From this, the most susceptible birds were selected to produce the SUS line and the
most resistant to produce the RES line. Based on the rapid divergence of the RES and SUS line
with each successive generation of selection, it was concluded that a limited number of genes
must be involved with resistance or susceptibility to ascites. Figure 1-4 shows this rapid
divergence through the ascites mortality for each of the three experimental lines in the first 10
generations of selection. The founder population had an average ascites mortality around 75%
when reared under hypoxic conditions. After selection began, the RES and SUS lines quickly
began to be driven toward the extremes of ascites mortality. By generation 10, the RES line
experienced ascites mortality of less than 10% while the SUS neared 90%. Figure 1-5 then shows
the trend in cumulative ascites mortality through day 42 for each line based on a single
generation during a hypobaric challenge. The SUS line not only reached nearly 100% ascites
mortality by the end of the challenge, but also saw onset of morbidity and mortality earlier than
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the other lines, starting between days 5 and 7 while the other lines did not see onset until 11 to 13
days. The RES line conversely reached ascites mortality of under 30% while the control
population of REL birds was near 70%. Additionally, trends in average bodyweight of birds from
the ascites lines as generations progressed were reported. Comparing the day 42 BW during a
hypobaric challenge, the RES and SUS lines both showed a negative linear trend with similar
day 42 BW by generation 10, however the RES exhibited the lowest BW. The 10-generation
trends in day 42 BW after being reared at ambient pressure also had a negative linear trend.
Between the lines in the tenth generation, the SUS outweighed the RES line by 163 grams,
providing further evidence of smaller birds tending to be more resistant to ascites. In terms of
heart condition when reared in the hypobaric chamber, generation 10 of selection exhibited the
lowest RVTV ratio in the RES line, the highest in the SUS line, with REL being intermediate.
Later, Krishnamoorthy et al. (129) completed a genome-wide SNP panel with the goal to
identify regions of the genome in linkage disequilibrium for susceptibility to ascites. The most
significant regions from that study were found on chromosome 9 and included the genes
angiotensin II type 1 receptor (AGTR1), urotensin 2 domain containing (UTS2D), and serotonin
receptor/transporter type 2B (HTR2B). A subsequent study revealed that AGTR1 and UTS2D
were not significantly associated with ascites in other populations (130).
Alzahrani (131) further studied the relationship between HTR2B and the variability in ascites
phenotype. First, SNPs in the HTR2B region were detected by PCR amplification and
sequencing, with 19 SNPs being found. Two were chosen: SNP586 which was associated with
the promoter region for HTR2B and SNP9093 which is located in exon 3. TaqMan exonuclease
assay primers and probes were designed to allow for genotype determination of DNAs of birds
that had been reared under hypobaric conditions for ascites phenotype from the ascites research
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lines and three commercial lines. After completing this analysis, it was found that HTR2B was
unlikely to be a universal QTL for ascites phenotype.
Tarrant et al. (132) utilized multi-generational genome-wide association studies (GWAS) to
identify new candidate regions associated with ascites. Generations 16 and 18 of the REL line
were assessed and regions significantly associated with ascites phenotype were identified on
chromosomes 2 and Z. Candidate genes coding for the melanocortin 4 receptor (MC4R) and
cadherin 6 (CDH6) were identified on chromosome 2, while myocyte enhancer factor 2c
(MEF2c) was identified on the Z chromosome. However, marker-assisted selection using these
regions indicated only minor contributions to ascites phenotype.
Dey et al. (133) identified the carboxypeptidase Q (CPQ) gene as a determinant of ascites
phenotype in broilers via whole genome resequencing (WGR). Birds from the eighteenth
generation of the REL line as well as birds from two commercial elite lines (one male line and
one female line) were reared in the hypobaric chamber for 6 weeks at simulated 9,000 feet
elevation. DNA was extracted from blood samples using a rapid method followed by organic
extraction and redissolution in Te (10 mM TrisCl pH 7.5, 0.1 mM EDTA) (134). After DNA
concentration was measured in each sample, 8 equal-weight pools of 10 DNAs each were created
with 2 replicates of each pool: susceptible males, resistant males, susceptible females, and
resistant females. These pools were then sequenced, giving 65 Gb of genomic data per pool.
After aligning the sequences to Galgal5 separately for each gender, the SNP data was then
exported for filtering; low coverage depth or missing SNP frequencies were filtered out. Finally,
a calculation of the difference in average SNP frequencies of the two pools of each phenotype
combination provided data that was plotted by chromosome position. This SNP frequency plot
was searched for clusters of SNPs with opposing SNP frequencies between the susceptible and
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resistant pools. The work initially focused on chromosome 2 based on the earlier data from
GWAS but whereas GWAS identified MC4R and CDH6, the WGR identified a different region
encompassing the 3’ end of the CPQ gene. Further genotyping based on SNPs in the CPQ gene
confirmed the association of this regions with ascites.
Following the work done by Dey et al., Parveen et al. (135) analyzed the WGR data for the
rest of the genome. This led to the detection of 28 regions on 13 chromosomes which
encompassed 64 genes including CPQ on chromosome 2 and leucine-rich repeat transmembrane
neuronal 4 (LRRTM4) on chromosome 22. This region was identified in both males and females
during WGR, making it a more promising candidate for genetic selection. LRRTM4 was found
to be associated with many human blood and metabolic traits based on information sourced from
the NCBI Phenotype-Genotype Integrator (136). Additionally, LRRTM4 was found to have an
epistatic interaction with CPQ and the two in combination showed even greater promise for
successful selection for ascites resistance.
Based on the available evidence from these studies, a MAS project was proposed that would
take the logical next step: starting from REL breeder stock and using the two previously
described validated genetic regions, breed two generations of MAS birds such that the F2
generation would have only non-reference SNPs in those regions. Then, assess the impact of the
genetic selection on ascites phenotype and on broiler production traits.
1.5 Infectious Bronchitis Virus
Infectious bronchitis (IB) is a respiratory illness caused by a gamma-coronavirus, infectious
bronchitis virus (IBV), which was originally identified in North Dakota in 1931 and is now
considered the second most threatening poultry disease (137–139). IBV has the capability to
cause economic losses in several ways, including bird death, decreased growth rate, and
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processing plant condemnations as well as the immense drop in egg production when IBV infects
a flock of layer hens (140). The severity of infection is unique between flocks as it is influenced
by the variant of the virus, environmental factors including but not limited to climate, ventilation,
or ammonia levels, and bird age, type, and immune status (141,142). Symptoms are also
understandably variable but can include coughing, sneezing, rales (clicking or rattling lung
sounds), conjunctivitis, facial swelling, depressed activity and huddling behavior, reduced feed
intake, and stunted weight gain (143). Initial infection through the respiratory tract causes
destruction to the cilia found in the nasal passageways and tracheal epithelium with the largest
viral load being found in the trachea three days after inoculation (140,144). In the cell, the virus
drives the production of proteins which either inhibit or induce apoptosis depending on the
tissue; in tissues directly related to symptomology, apoptosis is induced, while it is inhibited in
other nearby tissues (144,145). Some IBV strains also cause nephritis, damaging the renal system
after the initial respiratory symptomology including ruffled feathers, wet droppings, and
increased water intake (143,146). While some birds die from IBV directly, secondary bacterial
infections are the greater cause of overall mortality (140,141).
Due to the virus’ inherent rapid mutation rate producing numerous variants, IBV is difficult
to prevent using a vaccine and therefore the current prevention strategy involves one, or a
combination of vaccine strains, to hopefully protect the birds from the variants the birds are most
likely to encounter during their lifespan (137). Currently, live attenuated and inactivated IB
vaccines are the most commonly used in the commercial setting. Both options have associated
strengths and weaknesses. Live attenuated vaccines were the first successful IB prevention
utilized commercially and are administered through the drinking water or by spraying chicks
during the first 7 days (147). These vaccines, however, provide short-term immunity and require
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a booster in the weeks following the initial administration (140). Inactivated IB vaccines are
favorable in that they provide greater duration of protection when administered following a live
vaccine (148). The largest drawback to inactivate vaccines is their route of administration being
intramuscular injection which is less feasible in large-scale production operations.
Problematically, the immune response measured in vaccinated flocks has been found to be
extremely variable due to differences between flocks in bird type, flock size, and the specific
housing, lighting, and ventilation (149). This is in addition to the necessity and potential for
failure in finding the appropriate cocktail of vaccines to combat the variants most likely to be
encountered by a given flock. Due to this and the continual emergence of new local variants,
outbreaks continue to occur even in vaccinated flocks (150).
Given the challenges associated with preventing IBV using vaccines, it would be preferred to
have a more consistent option to reduce the occurrence of IB in flocks. An additional point of
interest warranting the study of IBV is its relationship with SARS-CoV-2. As previously stated,
IBV is a gamma-coronavirus while SARS-CoV-2 is a beta-coronavirus (151). Though the organ
system affected varies among coronaviruses, both gamma- and beta-coronaviruses cause
respiratory illnesses (152). With the success of the ascites MAS project, continued improvements
in the WGR pipeline, and the inherent connections to the COVID-19 pandemic, a project was
proposed that would elucidate the genetic determinants of resistance or susceptibility to IBV in
white leghorn chickens. This project would begin with an IBV challenge of young birds. Two
weeks post-challenge the birds would be euthanized and sampled for assessment of the level of
infection. Birds with high and low viral burdens could then be compared by WGR to identify
genetic regions of influence. Once found, these regions could be used in the breeding schemes of
layer hens in order to increase innate resistance to IBV.
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1.6 Figures
Figure 1-1: Driving factors for traditional versus modern phenotypic selection in commercial
breeding schemes (13).
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Figure 1-2: Breakdown of commercial broiler four-way breeding scheme (16).
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Figure 1-3: Physiological and pathophysiological flow of ascites development (89).
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Figure 1-4: Trend in ascites mortality of divergently selected ascites experimental lines over 20
generations of selection (128).
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Figure 1-5: Trend in ascites mortality of divergently selected ascites experimental lines through
the hypobaric challenge of one generation of birds (128).
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CHAPTER 2: SNP-BASED BREEDING FOR BROILER RESISTANCE TO ASCITES
AND EVALUATION OF CORRELATED PRODUCTION TRAITS
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2.1 Abstract
The goal of this study was to evaluate marker-assisted selection (MAS) in broiler chickens using
previously mapped gene regions associated with ascites syndrome incidence. The secondgeneration MAS products were assessed for impact on ascites phenotype and whether there were
associated changes in important production traits. Previously, we used whole genome
resequencing (WGR) to fine-map 28 chromosomal regions as associated with ascites phenotype
in our experimental ascites broiler line (Relaxed, REL) based on a hypobaric chamber challenge.
Genotypes for single nucleotide polymorphisms (SNPs) in mapped regions on chromosomes 2
and 22, were used for MAS in our REL line. After two generations, birds homozygous for the
genotypes associated with resistance for both chromosomal regions were established. The MAS
F2 generation was then compared to the REL line for ascites susceptibility and 25 production
traits. Selection based on SNPs in the carboxypeptidase Q (CPQ, Gga2) and leucine rich repeat
transmembrane neuronal 4 (LRRTM4, Gga22) gene regions resulted in a sex- and simulated
altitude- dependent reduction of ascites incidence in two F2 cohorts of the MAS line.
Comparisons of the F2 MAS and REL lines for production traits when reared at ambient pressure
found no significant negative impacts for feed intake (FI), feed conversion ratio (FCR), or
deboned part yields for either sex for two F2 cohorts. There were, however, improvements in the
MAS for full-trial body weight gain (BWG), FCR, absolute and relative tender weights, and
relative drumstick weight. These results validate the mapping of the 28 chromosomal regions and
demonstrate that fine mapping by WGR is an effective strategy for addressing a complex trait; it
also stands as the first successful SNP-based selection program against a complex disease trait,
such as ascites. The MAS line is comparable and, in some instances, superior, in growth
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performance to the REL control while being more resistant to ascites. This study indicates that
MAS based on WGR can provide significant breeding potential in agricultural systems.
2.2 Background
Since the 1950s, poultry breeding programs have selected for the increased ability of broilers
to rapidly accrete muscle tissue, thus minimizing grow-out time and increasing profits. There
have been, however, some negative results of this genetic progress, one of which is pulmonary
hypertension syndrome (PHS), or ascites. Traditionally, ascites has been associated with rearing
birds at higher elevations where partial pressures of oxygen are lower (1-11)(59,153,154), or in
colder rearing environments (12, 13). Ascites syndrome is the terminal result of prolonged
pulmonary hypertension, as liver damage releases ascitic fluid into the body cavity (9, 14, 15).
Prolonged hypertension is driven by increased oxygen demands of a rapidly growing body
supplied by an inadequate cardiopulmonary system (16-18). The incidence can be amplified as a
result of an oxygen-reduced environment(79), or increased thermoregulation in cold
environments (9, 15). The bird’s body increases blood flow, increasing O2 delivery, and
subsequently increases pulmonary blood pressure in an attempt to respond to metabolic
demands, which leads to incomplete gas exchange in the lungs (15, 19-21). Semi-oxygenated
blood is then sent to the organs with substantial detrimental effect on the liver, causing the
accumulation of abdominal fluid. It has been estimated that ascites is the cause of up to 8% of
broiler mortality and accounts for up to $100,000,000 in economic losses annually, making it
both a significant animal welfare and economic concern (6, 14, 15, 21-25).
Mitigation of ascites incidence has achieved varying degrees of success typically employing
i) feed restriction (1, 24, 26-31) , ii) nutrient density modification to reduce protein (29, 31-33),
or iii) feed additives such as arginine or antioxidants (29, 30, 34-37). Several of the methods for
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reducing ascites simply slow growth and negatively affect flock production performance.
Variability of efficacy found in these mitigation methods can result from genetic differences
between commercial lines, environmental variations due to geography, and flock management.
As ascites is estimated to have a relatively high heritability with reports ranging from 0.22 to
0.41, it is logical that increased ascites resistance through genetic selection could have significant
advantages and increase production potential (4, 11, 38-40).
Previous research at the University of Arkansas on the genetic basis of ascites involved the
development of three research lines from a commercial elite line through divergent selection for
ascites resistance when exposed to simulated high elevation conditions (11). The base population
(Relaxed, REL) for the selection study was derived from a commercial elite line in the 1990s and
maintained through random mating without selection. Sib-selection based on ascites phenotype
assessed through a 6-week hypobaric chamber challenge produced ascites resistant (RES) and
ascites susceptible (SUS) lines. Rapid response in divergent selection with successive
generations suggested a limited number of major genes. A series of genome-wide association
studies (GWAS) using SNP panels identified a few candidate SNPs as associated with ascites
phenotype, but subsequent MAS-based breeding projects were unsuccessful in validating these
few loci (41-44). More recently, whole genome resequencing (WGR) identified 28 genomic
regions where SNP clusters (100s to 1000s of SNPs) showed frequency bias with respect to
ascites phenotype (45, 46). Two of these regions were validated by further genotyping of
additional DNA samples and found to have potential epistatic interaction. One region spanned
more than 120 kbp on chromosome 2 including the 3’ end of the gene for carboxypeptidase Q
(CPQ). The second was an approximately 50 kbp region on chromosome 22 spanning the 3’ end
of the gene for leucine-rich repeat transmembrane neuronal 4 (LRRTM4). Both these genes have
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been associated in human GWAS with blood traits, heart rate, and blood pressure consistent with
factors contributing to ascites incidence in poultry.
Therefore, the current study reports on whether MAS based on SNP genotypes for the
regions of both CPQ and LRRTM4 can produce offspring with greater innate ascites resistance.
Since ascites susceptibility could potentially be linked to important production traits, we also
assessed the impact of selection on important broiler production traits.
2.3 Methods
All breeding, hatching, grow-out, and processing took place at the University of Arkansas
Poultry Research farm. All animal procedures were approved by the University of Arkansas
Institutional Animal Care and Use Committee (Approval Numbers 18083 and 18088) and
performed in accordance with relevant guidelines and regulations. This study is reported in
accordance with ARRIVE guidelines (https://arriveguidelines.org).
2.3.1 Bleeding, Genotyping, and Husbandry of Breeder Stock
Birds used for breeding were genotyped by collecting 10 µl of blood from the brachial vein
which was further processed using a rapid DNA extraction method (47). These DNAs were then
genotyped using exonuclease assays run in triplicate for both CPQ and LRRTM4 genes, as
described (45, 46). Selected breeders were then moved into individual breeder cages for
insemination and production of MAS offspring. At 18 wk, the birds were put on a lighting
schedule to induce egg production: a starting schedule of 12 hours light:12 hours dark that
progressed for 4 weeks to 16 hours light:8 hours dark, which was maintained through the
insemination/egg collection period. Insemination occurred two times weekly, and eggs were
collected daily and were labeled by hen. All eggs were stored at 18°C and 60% relative humidity
until sufficient numbers were reached to begin hatching the next generation.
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2.3.2 Hatchery Protocol
Sets of eggs were placed in a setting incubator (Jamesway Incubator Co., Cambridge,
Ontario, Canada) at 99.6°F and 85% relative humidity for 18 days. On d 18, the eggs were
candled, infertile eggs removed, fertile eggs placed into hatch baskets, and transferred by mating
combination to a hatching incubator (Jamesway Incubator Co.) at 98.0°F and 88% relative
humidity. On d 21, hatched chicks were wing-banded using different band colors for each subpopulation, and individual band numbers recorded.
2.3.3 Hypobaric Trials
For both hypobaric cohorts, birds of each line (MAS and REL) were mixed in one of 40
battery cages (measuring 0.6 × 0.6 × 0.3 m) with appropriate numbers from each line to maintain
even distribution throughout all the cages. No mortality data other than wing band number was
collected for the first week so that final mortality rates would not be confounded by chicks that
failed to start. For the remaining four weeks of the trial, the husbandry and necropsy methods
followed those described previously (11, 41, 44). As the birds grew, bird densities were reduced
in cages to maintain compliance with animal welfare requirements. Birds were initially chosen
for removal due to observation of clinical ascites phenotype through palpation of the abdomen.
All birds removed were euthanized and subsequently necropsied for ascites phenotype. Once all
birds showing ascites phenotype had been removed, additional birds were chosen at random to
meet welfare requirements and maintain consistent numbers for both lines. All birds remaining at
the end of 5 weeks were euthanized and necropsied to determine ascites phenotype.
2.3.4 Floor Trials
Hatches were placed in floor pens that were top-dressed with fresh pine shavings. Similar
numbers for each line were placed at similar densities. Surplus chicks were placed in a separate
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pen. Cardboard trays for feed were placed and remained in the pens for the first 7 days of the
trial. Feed and water were provided ad libitum throughout the trial. One continuous water line
per row of pens was adjusted as needed for bird height. Health inspections occurred twice daily
at a minimum. All mortalities were removed upon discovery and wing band number, pen of
origin, body weight, and any clinical observations including ascites incidence were recorded. If
available, the bird was replaced with another of the same sex and genetic line from the surplus
birds. Feed was formulated to Cobb-Vantress, Inc., industry recommended standards
(formulations can be found in Supplemental Table 1) and was added as needed throughout the
trial. Feeding phases were as follows: starter from placement to d 14, finisher from d 14 to d 35,
and withdrawal from d 35 to d 55. Pen weights were collected at time of placement, d 14, d 28, d
42, and d 49. Feed intake and feed conversion ratio (FCR) were recorded from d 49 until
processing.
2.3.5 Processing
The day prior to processing, a subset of each cohort consisting of 25 males and 25 females
per genetic line (n=100 per cohort) were randomly selected. These birds were removed from the
pen first on the morning of processing and were removed from the processing line prior to
evisceration to be necropsied for organ weights of liver, lungs (set), spleen, and heart, as well as
RVTV. These bird carcasses were not chilled or deboned. Also on the day prior to processing, a
second subset from each cohort were randomly chosen, consisting of 50 males and 50 females
per genetic line (n=200 per cohort). These birds were wing-banded to be assessed for MAS
impact on meat quality measurements of the breast fillet. Feed was removed 10 hours prior to
processing to ensure feed passage. All birds were collected the morning of processing and
transported to the University of Arkansas Poultry Pilot Processing Plant. At the processing plant,
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back dock live weight was collected prior to the birds being electrically stunned and
exsanguinated, followed by a scalding water bath to loosen feathers, then feather, head, and paw
removal. Carcasses were then eviscerated, and the hot carcass and fat pad weights were
collected. Carcasses were chilled for 3 hours and deboned thereafter for the determination of
absolute weight and relative (to back dock live weight) yield of wings, breasts, tenders, thighs,
and drumsticks. The 200 carcasses marked for further evaluation were processed as described but
also evaluated for muscle quality traits including breast fillet weight, color, and pH at 4- and 24hours chill time. The deviation between the 4- and 24-hour fillet weights were used to calculate
drip loss. Color and pH were measured using a Minolta CR-400 handheld model with PC-linked
SpectramagicX software and Testo model 205 handheld spear-tip probe, respectively. Color
readings were taken on the dorsal surface of the breast, while pH was measured in the cranial
region of the breast. The breasts were then frozen until the completion of both trials for cooking
and shear force measurements. Shear requirements were calculated based on four measurements
in the cranial region using a TA.XTPlus equipped with a Meullenet-Owens Razor Shear head
attachment.
2.3.6 Statistical Methods
All statistical analyses other than the survival model were conducted in R with statistical
significance denoted by a P-value ≤ 0.05.
Hypobaric mortality data were analyzed using a generalized linear model of final ascites
mortality as well as a survival model which showed the effect of genetic line and sex on the
probability of survival over time.
Live performance data were analyzed using two-way ANOVA between the main effects of
trial and genetic line. Parts weights, organ weights, heart characteristic, and meat quality
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characteristic data from processing were analyzed using three-way ANOVA between the main
effects of trial, genetic line, and sex. All means were separated by Tukey’s Honest Significant
Difference (HSD) test.
2.4 Results
2.4.1 First-Generation Breeding
Breeders for the first parent generation were selected from REL breeder stock in July of
2018. After bleeding and genotyping, two P0 crosses were then created: one consisting of birds
with all non-reference SNPs (compared to galGal6; 46) for each gene region, designated P0-1,
and the other consisting of birds with non-reference SNPs for CPQ and heterozygous SNPs for
LRRTM4, designated P0-2. P0-1 consisted of 10 males and 13 females; P0-2 consisted of 12
males and 24 females. Separately, ungenotyped REL birds were used to breed generation 1 of the
control population. Semen was collected from all the males of each P 0 group, pooled, and used to
artificially inseminate each of the females from the same P 0 group.
2.4.2 Second-Generation Breeding
After hatching, the F1 progeny produced from P0-1 and P0-2 were kept in floor pens and
managed as breeders until they reached 18 weeks of age, at which point they were then bled and
genotyped. Breeders for each F1 population were placed in individual breeder cages and photo
stimulated. In May of 2019, breeders from the F1 were selected based on being homozygous for
the non-reference SNPs for both genes; though all breeder SNP genotypes from this point
forward were the same, the F1 populations were kept separate in order to complete reciprocal
matings between them. Breeders from F1-1 (from P0-1) consisted of 12 males and 31 females; F12 (from P0-2) consisted of 12 males and 37 females. To produce the control group, 24 males and
72 females from the REL line were also utilized. Insemination began at the same time, when the
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MAS breeders were 22 weeks of age and the REL control breeders were 20 weeks of age. For
the REL, pooled semen from all 24 males were used to artificially inseminate all 72 REL
females. For the MAS, pooled semen from the F1-1 males was used to artificially inseminate the
F1-2 females and similarly the F1-2 males were used to inseminate the F1-1 females. This
reciprocal mating scheme produced the F2 generation of birds which would possess only the
non-reference SNPs for the CPQ and LRRTM4 genes. Sets of eggs for hatching included at least
250 eggs each from REL and the F2 of the MAS. At transfer, all eggs were candled and infertile
or eggs with embryonic mortality were removed and stored for breakout on hatch day along with
eggs that did not hatch; no significant difference (P>0.05) in hatchery breakout was found
between the two lines. After hatch, birds received a wing band that represented their genetic line
(either MAS or REL). Sets of eggs were produced every two weeks for four total hatches. The
first and fourth hatches were subjected to 5-week hypobaric challenges. The second and third
hatches were placed for 8-week floor pen trials to evaluate change in production traits associated
with MAS.
2.4.3 Hypobaric Challenges
F2 chicks for challenge in the hypobaric (Hypo) chamber were placed on November 28, 2019
(Hypo1) and January 8, 2020 (Hypo2). Hypo1 was maintained at 9,000 ft simulated altitude
while Hypo2 was initially set at 9,000 ft simulated altitude, then after 2 weeks increased to
11,000 ft simulated elevation to induce a higher incidence of ascites. In Hypo1, all hatched birds
were placed in the chamber (n=578) whereas in Hypo2, similar numbers of birds were placed
from each line and fewer total birds were placed (n=433) which reduced the number of birds that
would need to be culled for compliance with bird density regulations.
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The hypobaric challenge results indicate a sex- and elevation-dependent reduction in ascites
incidence in both cohorts. Hypo1 saw an overall decrease (P=0.041) in ascites mortality between
the MAS and REL birds, with a 27.3% reduction for ascites in MAS males and a 39.8% in MAS
females [Table 1]. For Hypo2, there was an overall numerical, although not statistically
significant (P=0.162), decrease in ascites mortality between the lines, with reductions of 23.4%
in males (P=0.126) and only 5.2% reduction in females [Table 2]. There was no significant
difference (P>0.05) between the lines for the right ventricle to total ventricle (RVTV) ratio or
body weight. The Kaplan-Meier survival model curve visually echoes these trends, however the
analyzed P-values from this model are only numerically different (P>0.05) [Figure 1].
2.4.4 Floor Trials
Birds reared for the floor trials were placed on December 12, 2019 (Floor1) and December
28, 2019 (Floor2). On the day of placement, the total number of hatched birds was counted for
each line and the number of birds placed per pen determined based on the smallest group; for
Floor1 this was 14 birds per pen (0.133 m2/bird) and for Floor2 13 birds per pen (0.143 m2/bird)
with all excess birds placed in spare pens for mortality replacement up until the beginning of the
FCR measurement period from d 49 to d 55. As both floor trials were run concurrently in the
same barn, though offset by two weeks, we considered whether the live performance and
processing data should be analyzed as completely separate trials with separate analyses or
together by adding the main effect of trial. After consultation with a professional agricultural
statistician and colleagues at the University of Arkansas, the latter option was chosen. However,
the interaction between line and trial was assessed for each measurement, and any traits
identified as having an interaction between line and trial were noted and are discussed.
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Conclusions about the overall effect of MAS on that particular measurement were not drawn in
those cases.
Live performance data from both cohorts is shown in Table 2. Significant differences were
found between trials: d0 body weight (BW) (P<0.001), d42 BW (P=0.038), d0-42 body weight
gain (BWG) (P=0.045), d49 BW (P=0.006), d0-49 BWG (P=0.007), d54 BW (P=0.017), and
full-trial BWG (P=0.019). Additionally, the genetic lines were significantly different in d49-54
BWG (P=0.036) and FCR (P<0.001), both of which were improved in the MAS. Significant
differences were found between trial and genetic line for d14 BW (P=0.019) and d0-14 BWG
(P=0.015).
2.4.5 Processing
Total sample sizes and tabular representations of the data are as follows: Table 3, live weight
and carcass characteristics (n=868); Table 4, deboned parts (n=868); Table 5, organ weights
(n=295); Table 6, heart characteristics (n=295); Table 7, meat quality characteristics (n=395). A
significant improvement was seen in the MAS birds for absolute and relative tender weights
(P<0.001, P<0.001, respectively), relative drumstick weight (P=0.016), and significant
differences were found for 24-hour L* color measurement (P<0.001), 24-hour a* color
measurement (P=0.037), and 24-hour pH (P=0.003). Significant differences were found between
sexes in relative hot carcass weight (P<0.001), wing weight (P<0.001), relative thigh weight
(P<0.001), relative drumstick weight (P<0.001), absolute and relative heart weight (P<0.001,
P=0.018, respectively), liver weight (P<0.001), lung weight (P<0.001), spleen weight (P<0.001),
RV weight (P<0.001), TV weight (P<0.001), drip loss (P<0.001), 24-hour L* color measurement
(P<0.001), 24-hour pH (P<0.001), and shearing peaks (P=0.016).
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Significant differences were also found between the two floor trials for many characteristics,
including wing weight (P<0.001), relative breast weight (P<0.001), relative thigh weight
(P<0.001), relative drumstick weight (P=0.002), relative heart weight (P<0.001), liver weight
(P=0.009), relative spleen weight (P=0.014), 24-hour a* color measurement (P=0.003), 24-hour
b* color measurement (P=0.017), 24-hour pH (P<0.001), and shearing peaks (P=0.002). Due to
this, there were also several significant interactions. Between trial and genetic line, significant
differences were found for RV weight (P=0.046), RVTV (P=0.005), shear force requirement
(P<0.001), and 1:3 shear area (P<0.001). While RV was found to be significantly different,
Tukey’s HSD test was unable to separate the means. RVTV was found to be the largest in MAS
birds from both trials and the smallest in REL birds from both trials. The largest shear force
measurements were found in the Floor2 REL breasts, with intermediate force requirements in the
Floor1 MAS group, and the lowest requirements in the Floor1 REL and Floor2 MAS groups.
The largest 1:3 shear area measurements were found in the Floor2 REL group, with all other
groups having comparable lower measurements.
A number of significant differences were found between trial and sex. These were live
weight (P=0.035), hot carcass weight (P=0.028), fat pad weight (P=0.019), chilled carcass
weight (P=0.036), absolute and relative tender weight (P=0.010, P=0.014, respectively), thigh
weight (P=0.025), drumstick weight (P=0.032), relative liver weight (P=0.032), shear force
requirement (P=0.010), and 1:3 shear area (P=0.040). The live weight and weights of hot carcass,
chilled carcass, and tenders were the largest for the Floor1 males, moderate for Floor2 males, and
smallest for females in both trials. The largest fat pads were found in the Floor1 males, moderate
for Floor1 females, small intermediate for Floor2 females, and smallest in Floor2 males. Relative
tender weight was found to be the greatest in Floor2 females, moderate in Floor1 females, and
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the lowest in males from both trials. The mean weights of thighs and drumsticks were separated
into four distinct groups, from largest to smallest being Floor1 males, Floor2 males, Floor1
females, and Floor2 females. The relative weight of liver was found to be the largest in females
from both trials and the smallest in males from both trials. For both the shear force requirement
and the 1:3 shear area, the measurements from Floor1 females were found to be the largest, the
Floor1 males were found to be the smallest, and both sexes in Floor2 were intermediate.
Finally, there were interactions found between genetic line and sex. These were live weight
(P=0.011) hot carcass weight (P=0.012), chilled carcass weight (P=0.019), breast weight
(P=0.050), thigh weight (P=0.006), drumstick weight (P=0.032), and 24-hour b* color
measurement (P=0.025). For live weight and the weights of hot carcass, chilled carcass, thighs,
and drumsticks, MAS males were found to be the largest, REL males were intermediate, and
females from both the MAS and REL lines were found to be the smallest. Breast weight was the
largest for males from both the MAS and REL lines, with the smallest weight in the females
from both lines. The 24-hour b* color measurement was found to be the highest in MAS females,
with the three other groups having comparable lower b* measurements.
There was also a single three-way interaction (P=0.039) found for the processing
measurements, which was fat pad. In order from largest to smallest, the means were separated as
follows: Floor1 MAS females, Floor1 REL females, Floor2 females from both lines, Floor1 REL
males, Floor1 MAS males, Floor2 MAS males, and Floor2 REL males.
2.5 Discussion
Ascites has been reported to have a significant sex-dependent incidence in flocks (39, 48). In
the REL line, females show an earlier onset and higher overall incidence of ascites (11).
However, a reduction of ascites incidence was observed between MAS females of the first and
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fourth cohorts for hypobaric challenges where the simulated altitude differed. At moderate
elevations (9,000 ft) in Hypo1, ascites incidence was reduced by nearly 40% for the MAS
females, while at higher simulated altitude (11,000 ft) in Hypo2, there was only a 5% reduction
of female mortality from 61.9% in the REL line to 58.7% in the MAS line. For males, incidence
was reduced in the MAS line by 27% in Hypo1, while being reduced by 23% in Hypo2 with the
increased simulated altitude. This further demonstrates the sex-linked nature of ascites resistance
or susceptibility and suggests more research into epistasis with genes on the sex chromosomes
are warranted. Additional research into the impact of MAS on each sex is also warranted. The
timeline of this study, and the capacity of the hypobaric chamber, did not allow for single-sex
experiments to allow for greater sample sizes. However, even with relatively small cohort sizes,
significant reduction of ascites for the MAS line was observed.
An additional point of success in these results comes from the lack of impact on production
traits. If MAS negatively impacted economically important traits in any major way, then MAS
would be much less appealing to the industry. From the live production data, a significant
improvement of the MAS was found in body weight gain from the full trial and in FCR. A
limited number of traits showed significant differences between overall MAS and REL averages,
all of which were improved in the MAS birds; these were absolute and relative tender weights
and relative drumstick weight. Additionally, there were some improvements in the MAS that
were only seen in one sex. These were live weight, hot carcass, chilled carcass, thigh weight, and
drumstick weight, all of which were larger in MAS males over REL males while the MAS and
REL female measurements in each of these cases were statistically equivalent. Given these
improvements, MAS appears to be not only capable of reducing ascites incidence, but to have a
positive impact on some growth characteristics. Notably, there was a significant three-way
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interaction between trial, genetic line, and sex for fat pad weight relative to back-dock live
weight. From the trend in this characteristic, we observed that the females from each cohort had
larger relative fat pad weights than the males, but as this did not have an impact on the trends of
the deboned parts data, we are less concerned about this outcome.
We also identified differences between MAS and REL for breast color measurements. The
measurement of each breast fillet was broken into three components: L* represents the lightness
from 0 (black) to 100 (white); a* represents the color spectrum from -60 (green) to +60 (red); b*
represents the color spectrum from -60 (blue) to +60 (yellow) (155). A significant difference was
found in the L* and a* measurements between the two genetic lines, and in the L* measurement
between the sexes. The difference in L* measurements between the two genetic lines is
especially interesting as this means that MAS line breast fillets were consistently lighter in color
than the REL. While the classification of Qiao et al. (50) considers all of the L* measurements
from both cohorts except for MAS female to be “normal” in lightness (MAS female would be
classified as “lighter than normal”). This color difference is difficult to visually discern, however
fillets with higher L* values may have higher moisture contents. Thus, the fillets from MAS may
have consistently greater moisture than the REL. The data also showed an interaction between
genetic line and sex with the b* measurement. However, other changes occurred that were only
numeric; some measurements increased nearly one unit between the two cohorts, others changed
which group had a greater value for a particular measurement. These variations could trace back
to minor differences in formulation of individual batches of feed used for the two trials or to
other causes still unknown. While these are relatively small fluctuations, it is difficult to know
exactly how much of an impact it might have on consumer perspective of the color of these
fillets (51).
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These data validate the WGR approach for identifying regions for MAS for improving
multigene traits in commercial breeding programs. However, there are limitations. One limitation
is that the regions we identified in REL by WGR may not be relevant in current elite lines. The
REL is the unselected descendant from a commercial elite line from the 1990s (11). The genetics
of modern elite broiler lines have undoubtedly changed in the ensuing two decades. WGR for
ascites in two current commercial broiler crosses did not find associations with either the CPQ or
LRRTM4 regions (unpublished). Current elite lines could be subjected to WGR using the
hypobaric chamber challenge to identify line-specific regions associated with ascites phenotype.
Despite the unique and proprietary nature of each commercial line, each could be assessed
individually, candidate gene regions validated, and then informative regions included in selection
programs. Alternatively, commercial broilers could be subjected to WGR to identify the regions
to be selected for in the elite lines to produce the required genetics in the terminal cross for
production of those broiler products. Further research and MAS projects for the major modern
commercial crosses are needed to fully understand the efficacy of this method against ascites.
Though its prevalence in the US market varies by specific commercial products (unpublished
data) and geographical region, ascites still remains problematic in the global market given
worldwide variation in climates, elevations, and management strategies. Published data for
mortality and economic impact are nearing or surpass two decades old (21, 25), warranting new
assessments of the impact on the US and global markets. Based on existing statistics, significant
reduction could potentially prevent millions of bird deaths, saving millions of dollars for the
industry. Our results document that genetics can be used to significantly reduce ascites without
compromising production.
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2.6 Conclusions
These results represent the first documented success in fine-mapping and marker-assisted
selection for a complex trait in a poultry species. WGR has the potential to not only identify
other genetic regions for selection against ascites, but also for other complex traits. One problem
with general selection against ascites is the tendency for smaller birds to be more resistant to the
disease (32, 52), meaning strictly phenotype-based selection could negatively impact growth rate
and feed efficiency. Given the specificity of the regions utilized in our MAS experiment, there is
a strong potential that they could be easily integrated into the current breeding programs of
poultry genetics companies. This could increase innate resistance to ascites without having to
“back-track” over years of selection for growth traits. WGR and MAS hold great promise for
targeted genetic selection in agricultural systems.
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2.7 Tables and Figures
Figure 2-1 Survival plots for the two hypobaric chamber challenges comparing the MAS and
REL lines according to sex.
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Table 2-1. Ascites incidence and cardiac hypertrophy (RVTV) for the two hypobaric trials
comparing the MAS and REL lines overall and by gender.
Ascites
Percent, %

n
RVTV
No
Yes
Difference, %
Item
Hypobaric trial 1
Sex
Male
274
0.305
237
37
13.50
28.00
Female
304
0.321
247
57
18.75
Line
MAS
332
0.310
288
44
13.25
34.83
REL
246
0.318
196
50
20.33
Interactions
155
0.299
137
18
11.61
Male  MAS
27.27
119
0.314
100
19
15.97
Male  REL
177
0.319
151
26
14.69
Female  MAS
39.82
127
0.323
96
31
24.41
Female  REL
P-value
Sex
0.009
0.047
Genetic Line
0.160
0.041
0.367
0.742
Sex  Line
Hypobaric Trial 2
Sex
Male
186
0.387
108
78
41.94
30.47
Female
247
0.421
98
149
60.32
Line
MAS
212
0.403
108
104
49.06
11.86
REL
221
0.410
98
123
55.66
Interactions
91
0.39
58
33
36.26
Male  MAS
23.44
95
0.39
50
45
47.37
Male  REL
121
0.42
50
71
58.68
Female  MAS
5.21
126
0.43
48
78
61.90
Female  REL
P-value
Sex
<0.001
<0.001
Genetic Line
0.404
0.162
0.550
0.415
Sex  Line
Abbreviations: MAS = marker-assisted selection line; REL = Relaxed (control) line; RV =
right ventricle; TV = total ventricle
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Table 2-2. Live performance data from the replicate floor trials.
d49-54
FI,
FCR,
g/bird
g:g
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d0,
d14,
d28,
d42,
d49,
d54,
BWG,
Item
n
g/bird
g/bird
g/bird
g/bird
g/bird
g/bird
g/bird
Main effect of trial
Floor1
40 38.00a
255.0a
934.8
1987a
2522a
2888a
365.5
0.932
2.566
b
b
b
b
b
Floor2
40 36.65
236.7
947.7
1949
2458
2822
368.3
0.937
2.560
SEM
0.15
2.1
6.3
13
16
20
4.6
0.007
0.021
Main effect of genetic line
MAS
40
37.30
246.4
940.3
1976
2507
2875
372.9a
0.935
2.512b
REL
40
37.35
245.3
942.2
1960
2474
2835
361.0b
0.933
2.613a
SEM
0.19
2.8
6.4
13
17
20
4.3
0.007
0.021
Trial  Line
20
38.06
252.4a
927.9
1993
2541
2909
368.4
0.928
2.523
Floor1  MAS
a
20
37.94
257.6
941.8
1981
2504
2867
362.5
0.935
2.609
Floor1  REL
b
20
36.54
240.4
952.6
1960
2473
2842
377.7
0.943
2.500
Floor2  MAS
20
36.76
233.0b
942.7
1939
2444
2803
359.5
0.931
2.618
Floor2  REL
SEM
0.22
3.2
9.7
21
26
31
7.1
0.010
0.031
P-values
Trial
<0.001
<0.001
0.142
0.038
0.006
0.017
0.585
0.583
0.773
Genetic line
0.800
0.674
0.819
0.358
0.155
0.137
0.036
0.812
<0.001
0.393
0.019
0.174
0.801
0.872
0.946
0.279
0.303
0.536
Trial  Line
Abbreviations: Floor1 = Floor cohort 1; Floor2 = Floor cohort 2; MAS = marker-assisted selection line; REL =
Relaxed (control) line; d = day; BWG = body weight gain; FI = feed intake; FCR = feed conversion ratio

Table 2-3. Live weight and carcass characteristics from the replicate floor trials.
Item

n

Main effect of trial
Floor1
453
Floor2
415
SEM
Main effect of genetic line
MAS
439
REL
429
SEM
Main effect of sex
Male
395
Female
473
SEM
Trial  Line
233
Floor1  MAS
220
Floor1  REL
206
Floor2  MAS
209
Floor2  REL
SEM
Trial  Sex
204
Floor1  Male
249
Floor1  Female
191
Floor2  Male
224
Floor2  Female
SEM
Line  Sex
209
MAS  Male
230
MAS  Female
186
REL  Male
243
REL  Female
SEM
Trial  Line  Sex
Floor1 x MAS x Male
114
Floor1 x MAS x Female 118
Floor1 x REL x Male
90
Floor1 x REL x Female 127
Floor2 x MAS x Male
95
Floor2 x MAS x Female 111
Floor2 x REL x Male
96
Floor2 x REL x Female 113
SEM
P-values
Trial
Genetic line
Sex
Trial  Line

Live
Weight,
kg

Hot carcass
Fat pad
Chilled carcass
Weight, Yield1, % Weight, Yield, % Weight, Yield, %
kg
kg
kg

2814a
2730b
19

1996a
1941b
14

70.94
71.11
0.07

67.20a
59.53b
0.88

2.402a
2.194b
0.030

2058a
2002b
14

73.13
73.35
0.07

2795a
2752b
19

1988a
1951b
14

71.12
70.91
0.07

64.03
63.00
0.91

2.307
2.297
0.031

2050a
2013b
14

73.33
73.14
0.07

3117a
2488b
13

2223a
1759b
10

71.33a
70.75b
0.07

65.56a
61.81b
0.91

2.104a
2.469b
0.029

2281a
1823b
10

73.22
73.25
0.08

2826
2803
2761
2699
27

2010
1983
1964
1918
20

71.09
70.77
71.15
71.06
0.10

67.00
67.42
60.67
58.41
1.36

2.385
2.420
2.218
2.170
0.045

2072
2045
2025
1979
20

73.29
72.97
73.38
73.33
0.11

3174a
2513c
3055b
2460c
19

2264a
1773c
2180b
1743c
15

71.29
70.65
71.38
70.87
0.10

70.71a
64.31b
60.07c
59.08bc
1.29

2.236
2.540
1.962
2.391
0.042

2322a
1838c
2238b
1806c
15

73.13
73.14
73.32
73.38
0.11

3147a
2476c
3085b
2498c
21

2248a
1753c
2197b
1764c
16

71.42
70.84
71.23
70.67
0.10

66.98
61.33
63.95
62.27
1.38

2.128
2.469
2.076
2.468
0.042

2306a
1818c
2255b
1827c
16

73.30
73.36
73.13
73.15
0.11

2.201cd
2.564a
2.281bcd
2.518ab
2.042de
2.369abc
1.883e
2.413abc
0.062
<0.001
0.008
<0.001
0.235

<0.001
0.003
<0.001
0.432

0.078
0.054
<0.001
0.293
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<0.001
0.313
0.002
0.274

<0.001
0.618
<0.001
0.349

<0.001
0.003
<0.001
0.468

0.270
0.069
0.640
0.174

Table 2-3 (Cont.)
0.035
0.028
0.514
0.019 0.108
0.036 0.909
Trial  Sex
0.011
0.012
0.942
0.200
0.628
0.019 0.915
Line  Sex
0.980
0.992
0.637
0.093 0.039
0.963 0.889
Trial  Line  Sex
Abbreviations: Floor1 = Floor cohort 1; Floor2 = Floor cohort 2; MAS = marker-assisted selection line;
REL = Relaxed (control) line
1: Yields calculated based on back-dock live weight
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Table 2-4. Deboned parts characteristics from the replicate floor trials.
Wings
Breast fillets
Tenders
1
Weight, Yield , Weight,
Weight,
Yield, %
Yield, %
Item
n
kg
%
kg
kg
Main effect of trial
Floor1
453 223.2a
7.947 431.6
15.33b
112.2
4.001b
Floor2
415 216.6b
7.936 432.4
15.79a
111.2
4.080a
SEM
1.5
0.020
3.7
0.07
0.8
0.020
Main effect of genetic line
MAS
439
221.2
7.928 435.9
15.57
114.0a
4.091a
b
REL
429
218.9
7.956 427.9
15.54
109.5
3.985b
SEM
1.5
0.020
3.7
0.07
0.8
0.018
Main effect of sex
Male
395 247.5a
7.943 483.2a
15.49
121.8a
3.907b
b
b
b
Female
473 197.2
7.940 389.1
15.60
103.3
4.149a
SEM
1.0
0.019
3.2
0.07
0.7
0.018
Trial  Line
233
224.1
7.925 436.7
15.37
114.4
4.057
Floor1  MAS
220
222.2
7.970 426.1
15.29
110.0
3.941
Floor1  REL
206
217.9
7.932 435.0
15.79
113.5
4.130
Floor2  MAS
209
215.4
7.940 429.8
15.80
108.9
4.031
Floor2  REL
SEM
2.2
0.029
5.3
0.10
1.2
0.029
Trial  Sex
204
252.1
7.938 486.7
15.34
123.6a
3.899c
Floor1  Male
c
249
199.4
7.954 386.2
15.33
102.7
4.084b
Floor1  Female
191
242.5
7.949 479.4
15.66
119.9b
3.915c
Floor2  Male
224
194.7
7.925 392.3
15.90
104.0c
4.220a
Floor2  Female
SEM
1.3
0.029
4.7
0.10
1.1
0.027
Line  Sex
209
248.8
7.911 489.8a
15.53
124.2
3.944
MAS  Male
230
196.3
7.944 387.0b
15.60
104.7
4.225
MAS  Female

Thighs
Drumsticks
Weight,
Weight,
Yield, %
Yield, %
kg
kg
380.4a
362.7b
3.3

13.47a
13.25b
0.05

271.9a
260.3b
2.1

9.653a
9.537b
0.027

376.3a
367.5b
3.3

13.41
13.31
0.05

269.8a
262.9b
2.1

9.649a
9.546b
0.027

427.6a
325.4b
2.5

13.71a
13.07b
0.05

302.7a
236.2b
1.5

9.723a
9.494b
0.027

383.5
377.4
368.2
357.1
4.7

13.53
13.39
13.27
13.22
0.08

274.7
269.1
264.1
256.5
3.0

9.717
9.586
9.571
9.504
0.040

439.6a
330.9c
414.8b
319.3d
3.6

13.85
13.15
13.57
12.97
0.08

310.2a
240.0c
294.7b
231.9d
2.0

9.779
9.550
9.662
9.433
0.038

434.2a
323.7c

13.79
13.07

306.8a
236.4c

9.765
9.544

Table 2-4 (Cont.)
186
246.0
7.980 475.8a
15.45
119.4
3.865
420.6b
13.63
298.5b
9.675
REL  Male
b
c
c
243
198.0
7.937 391.0
15.61
101.8
4.076
326.7
13.06
235.7
9.447
REL  Female
SEM
1.7
0.028
5.0
0.11
1.1
0.026
3.7
0.08
2.3
0.041
P-values
Trial
<0.001
0.630 0.834 <0.001
0.296
<0.001
<0.001 <0.001
<0.001
0.002
Genetic line
0.840
0.286 0.324
0.665 <0.001
<0.001
0.003
0.258
<0.001
0.016
Sex
<0.001
0.773 <0.001
0.180 <0.001
<0.001
<0.001 <0.001
<0.001 <0.001
0.085
0.393 0.698
0.532
0.924
0.631
0.404
0.897
0.564
0.563
Trial  Line
0.053
0.558 0.079
0.210
0.010
0.014
0.025
0.481
0.032
0.903
Trial  Sex
0.213
0.185 0.050
0.538
0.339
0.127
0.006
0.287
0.032
0.842
Line  Sex
0.245
0.073 0.568
0.441
0.725
0.668
0.607
0.251
0.906
0.827
Trial  Line  Sex
Abbreviations: Floor1 = Floor cohort 1; Floor2 = Floor cohort 2; MAS = marker-assisted selection line; REL = Relaxed (control)
line
1: Yields calculated based on back-dock live weight
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Table 2-5. Organ weights from the replicate floor trials.
Heart
Weight, Yield1,
g
%

Liver
Lungs
Spleen
Weight,
Weight,
Weight,
Yield, %
Yield, %
Yield, %
g
g
g

Item
n
Main effect of trial
Floor1
95
14.95
0.626b 50.91a
2.108
15.78
0.663
2.878
0.122b
a
b
Floor2
100
15.17
0.666 47.51
2.077
15.47
0.680
3.083
0.135a
SEM
0.30
0.009
1.05
0.034
0.36
0.013
0.079
0.003
Main effect of genetic line
MAS
98
15.07
0.643
49.78
2.108
15.43
0.663
3.001
0.129
REL
97
15.06
0.651
48.58
2.076
15.82
0.681
2.965
0.128
SEM
0.31
0.009
0.98
0.030
0.37
0.013
0.080
0.003
Main effect of sex
Male
98
17.01a
0.660a 51.42a
1.983b 17.16a
0.664
3.176a
0.123
b
b
b
a
b
Female
97
13.10
0.633
46.88
2.208
14.09
0.680
2.788b
0.134
SEM
0.20
0.008
1.05
0.032
0.34
0.013
0.083
0.003
Trial  Line
48
15.02
0.624
51.40
2.111
15.78
0.661
2.808
0.118
Floor1  MAS
47
14.88
0.629
50.43
2.105
15.78
0.665
2.951
0.125
Floor1  REL
50
15.11
0.660
48.18
2.106
15.09
0.664
3.186
0.139
Floor2  MAS
50
15.24
0.671
46.84
2.048
15.85
0.696
2.978
0.130
Floor2  REL
SEM
0.49
0.013
1.57
0.050
0.57
0.019
0.114
0.004
Trial  Sex
48
17.00
0.638
52.54
1.960b 17.51
0.655
3.098
0.116
Floor1  Male
a
47
12.88
0.615
49.26
2.269
14.05
0.671
2.655
0.127
Floor1  Female
b
50
17.02
0.681
50.34
2.006
16.81
0.672
3.250
0.129
Floor2  Male
13.31
0.650
44.61
2.151a 14.13
0.689
2.914
0.140
Floor2  Female 50
SEM
0.31
0.013
1.72
0.050
0.57
0.022
0.122
0.004
Line  Sex
48
17.19
0.663
52.28
1.999
17.01
0.654
3.231
0.124
MAS  Male
50
13.02
0.623
47.33
2.220
13.95
0.670
2.780
0.134
MAS  Female
50
16.83
0.657
50.58
1.969
17.31
0.672
3.122
0.122
REL  Male
47
13.19
0.644
46.45
2.194
14.22
0.690
2.798
0.134
REL  Female
SEM
0.32
0.012
1.50
0.049
0.50
0.019
0.133
0.005
P-values
Trial
0.434 <0.001
0.009 0.348
0.470
0.332
0.052
0.014
Genetic Line
0.999 0.466
0.357 0.508
0.370
0.283
0.731
0.446
Sex
<0.001 0.018 <0.001 <0.001 <0.001
0.322 <0.001
0.556
0.646 0.707
0.888 0.396
0.384
0.447
0.116
0.130
Trial  Line
0.469 0.690
0.347 0.032
0.364
0.964
0.636
0.610
Trial  Sex
0.363 0.284
0.752 0.948
0.971
0.986
0.580
0.978
Line  Sex
0.284
0.396
0.601
0.660
0.396
0.692
0.806
0.652
Trial  Line  Sex
Abbreviations: Floor1 = Floor cohort 1; Floor2 = Floor cohort 2; MAS = marker-assisted selection line;
REL = Relaxed (control) line
1: Yields calculated based on back-dock live weight
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Table 2-6. Heart characteristics from the replicate floor trials.
Item
n
RV, g
TV, g
RVTV
Main effect of trial
Floor1
95
2.306
10.31
0.225a
Floor2
100
2.270
10.43
0.217b
SEM
0.056
0.22
0.003
Main effect of genetic line
MAS
98
2.284
10.40
0.220
REL
97
2.292
10.34
0.222
SEM
0.059
0.22
0.003
Main effect of sex
Male
98
2.589a
11.85a
0.219
b
Female
97
1.986
8.87b
0.223
SEM
0.044
0.14
0.003
Trial  Line
48
2.354a
10.41
0.230a
Floor1  MAS
47
2.259a
10.20
0.220ab
Floor1  REL
a
50
2.218
10.40
0.210a
Floor2  MAS
50
2.323a
10.46
0.224ab
Floor2  REL
SEM
0.091
0.36
0.005
Trial  Sex
48
2.618
11.96
0.221
Floor1  Male
47
1.995
8.64
0.230
Floor1  Female
50
2.562
11.76
0.218
Floor2  Male
50
1.979
9.09
0.216
Floor2  Female
SEM
0.066
0.21
0.004
Line  Sex
48
2.609
12.04
0.218
MAS  Male
50
1.978
8.83
0.221
MAS  Female
50
2.571
11.68
0.220
REL  Male
47
1.995
8.91
0.224
REL  Female
SEM
0.075
0.24
0.005
P-values
Trial
0.538
0.499
0.049
Genetic Line
0.802
0.712
0.517
Sex
<0.001
<0.001
0.481
0.046
0.489
0.005
Trial  Line
0.691
0.078
0.192
Trial  Sex
0.630
0.237
0.862
Line  Sex
0.907
0.154
0.075
Trial  Line  Sex
Abbreviations: Floor1 = Floor cohort 1; Floor2 = Floor cohort 2;
MAS = marker-assisted selection line; REL = Relaxed (control)
line; RV = right ventricle; TV = total ventricle.
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Table 2.7. Meat quality characteristics from the replicate floor trials.
24-hr Color
Drip
n
L*(D65) a*(D65)
b*(D65)
Item
loss1, g
Main effect of trial
Floor1
198
2.052
52.34
2.050a
8.932a
b
Floor2
197
2.165
52.72
1.776
8.607b
SEM
0.116
0.19
0.071
0.108
Main effect of genetic line
MAS
196
2.161
53.03a
1.805b
8.956a
b
a
REL
199
2.047
52.04
2.011
8.582b
SEM
0.114
0.19
0.069
0.107
Main effect of sex
Male
198
1.612b 51.50b
1.923
8.384b
a
a
Female
197
2.617
53.56
1.893
9.157a
SEM
0.125
0.18
0.071
0.106
Trial  Line
97
2.117
52.89
1.905
9.093
Floor1  MAS
101
1.990
51.79
2.190
8.774
Floor1  REL
99
2.204
53.16
1.706
8.821
Floor2  MAS
98
2.106
52.30
1.824
8.389
Floor2  REL
SEM
0.166
0.27
0.103
0.155
Trial  Sex
101
1.460
51.12
2.152
8.469
Floor1  Male
97
2.696
53.56
1.945
9.414
Floor1  Female
97
1.771
51.89
1.682
8.295
Floor2  Male
100
2.542
53.56
1.842
8.908
Floor2  Female
SEM
0.179
0.27
0.113
0.149
Line  Sex
98
1.670
51.80
1.855
8.411b
MAS  Male
98
2.663
54.25
1.754
9.506a
MAS  Female
100
1.556
51.20
1.992
8.356b
REL  Male

Shear
24-hr pH

Force (N)

Area 1:3

Peaks

5.946a
5.857b
0.013

14.04
14.26
0.23

187.7
191.9
2.7

8.823b
9.545a
0.182

5.875b
5.926a
0.013

13.85b
14.45a
0.22

184.0b
195.6a
2.6

8.981
9.384
0.179

5.935a
5.866b
0.013

13.76b
14.55a
0.22

186.0b
193.7a
2.7

8.859b
9.512a
0.187

5.925
5.966
5.825
5.885
0.018

14.32ab
13.78b
13.39b
15.14a
0.33

189.1b
186.5b
179.0b
204.9a
3.9

8.521
9.113
9.427
9.667
0.268

5.980
5.910
5.888
5.822
0.019

13.28b
14.83a
14.26ab
14.28ab
0.33

180.4b
195.3a
191.9ab
192.1ab
3.9

8.441
9.229
9.299
9.783
0.290

5.916
5.833
5.954

13.62
14.09
13.91

180.7
187.3
191.3

8.699
9.265
9.018

Table 2-7 (Cont.)
99
2.570
52.88
2.029
8.811b
5.898
15.01
200.0
9.758
REL  Female
SEM
0.178
0.26
0.104
0.156
0.019
0.32
4.0
0.264
P-values
Trial
0.629
0.113
0.003
0.017
<0.001
0.457
0.239
0.002
Genetic Line
0.515
<0.001
0.037
0.009
0.003
0.045
0.001
0.060
Sex
<0.001
<0.001
0.803
<0.001
<0.001
0.009
0.031
0.016
0.908
0.611
0.367
0.757
0.622
<0.001
<0.001
0.378
Trial  Line
0.128
0.112
0.052
0.236
0.848
0.010
0.040
0.681
Trial  Sex
0.967
0.112
0.456
0.025
0.473
0.287
0.778
0.555
Line  Sex
0.096
0.794
0.290
0.694
0.766
0.803
0.956
0.667
Trial  Line  Sex
Abbreviations: Floor1 = Floor cohort 1; Floor2 = Floor cohort 2; MAS = marker-assisted selection line; REL = Relaxed
(control) line
1: Drip loss calculated as the difference in breast weight before and after 24-hour chill
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CHAPTER 3: WHOLE GENOME RESEQUENCING SUGGESTS LIMITED GENETIC BASIS
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FOR WIDE VARIATION IN INFECTIOUS BRONCHITIS VIRAL LOAD IN CHALLENGED
NAÏVE WHITE LEGHORN CHICKENS

74

3.1 Abstract
Infectious bronchitis virus (IBV) is a gamma-coronavirus which causes respiratory illness and
mortality in poultry species. The goal of this study was to complete whole genome resequencing
(WGR) on a population of IBV-challenged birds to map genomic regions associated with IBV
severity. Specific pathogen-free white leghorn chickens were challenged at 18 days of age with
an Arkansas-type virulent IBV strain, then 5 days later sampled to quantify viral load in the
trachea. DNA from the 48 lowest and highest viral titers were used for the WGR analysis. Three
pipelines were utilized to process the data varying on removal of PCR artifacts and pool size for
comparisons. Although each pipeline identified regions only a single region on chromosome 18
containing two genes (ARHGAP44 and CDRT1) was found in multiple pipelines. In humans,
ARHGAP44 has been associated with viral pathogenesis and immune function. Further
investigation of this gene in non-naïve populations is warranted to further assess this regions
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contribution to IBV susceptibility in poultry.
3.2 Introduction
Infectious bronchitis (IB) is a highly contagious respiratory illness causing major economic
losses to the global poultry industry. Chickens of all ages are susceptible, but younger birds
commonly suffer a more severe disease (1). IB virus (IBV), a gamma-coronavirus, is known to
infect all members of the Gallus gallus species. Various genetic factors underlying the chicken
immune response have been associated with susceptibility and resistance to IB. The main
considerations have been in relation to different major histocompatibility complex (MHC) (or B
complex) haplotypes (2,3). Nevertheless, upregulation of proinflammatory responses by nonMHC genes have also been associated with susceptibility to IBV (3,4).
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While a larger scope of research has been directed to understanding differences in resistance
to IBV between B complex haplotypes, limited information is available on other genetic
determinants that could be associated with resistance to IBV. We have previously demonstrated
that Whole Genome Resequencing (WGR) can fine map genetic determinants of complex traits
in poultry (5,6). WGR identifies contiguous regions of hundreds to thousands of single
nucleotide polymorphisms (SNPs) spanning 10-1000 kbp differentially represented in the
phenotypic tails of a trait. The approach has been validated using marker assisted selection to
breed for resistance to ascites (7). Given the recent pandemic-related interest in highly infectious
coronaviruses, and the significant costs of IBV in the poultry industry, we have investigated
whether WGR can be used to identify gene regions associated with IBV resistance.
3.3 Methods
3.3.1 Chickens
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Four hundred specific pathogen-free (SPF) white leghorn chickens (Charles River
Laboratories, Norwich, CT) were hatched, individually wing-banded, and maintained in floor
pens in biosafety level 2 facilities, with water and food ad libitum. All procedures and animal
care followed federal and institutional standards at the Auburn University College of Veterinary
Medicine and approved by the Auburn University Institutional Animal Care and Use Committee
(Approval #2020-3754) and performed in accordance with relevant guidelines and regulations.
3.3.2 Experimental Design
At 18 days of age, all chickens were challenged with an Arkansas (Ark)-type virulent IBV
(GenBank accession No. JN861120) previously characterized (8). Challenge was performed
ocularly with 50µl of viral suspension containing 104 embryo infectious doses 50% (EID50) per
chicken. All chickens were euthanized 5 days after challenge for sampling and gender
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determination. Males were not investigated in the current study. Viral load (IBV RNA) in the
tracheas was measured in all female chickens by quantitative real time polymerase chain reaction
(qRT-PCR). Tracheal samples were also collected from all birds for histomorphometry. From a
total of 198 female chickens, 48 chickens showing the lowest and 48 chickens showing the
highest relative viral RNA loads in the trachea were selected for WGR. In addition, tracheal
mucosal thickness of both groups, i.e., high and low IBV RNA, was determined by
histomorphometry.
3.3.3 Viral Load
Tracheal samples were homogenized with TriReagent (Molecular Research Center,
Cincinnati, OH) and total RNA was extracted using the Zymo Research Direct-zol RNA
Miniprep kit (Zymo Research Corporation, Irvine, CA). With the exception of omitting the
DNase I treatment, the manufacturer’s protocol was followed. Total RNA was quantified using
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NanoDrop spectroscopy (Thermo Scientific, Waltham, MA) and diluted below 170 ng/µl prior to
qRT-PCR. Viral loads (IBV RNA) were determined using TaqMan qRT-PCR as described (9).
The relative viral copy number from qRT-PCR was divided by the total RNA concentration
input.
3.3.4 Histomorphometry
Tracheae were fixed in 10% neutral buffered formalin and sectioned along the median axis.
Sections of trachea were then routinely processed, embedded in paraffin, sectioned at 4 to 6 µm,
and stained with hematoxylin and eosin for histomorphometry. Five repeated measures were
individually taken for mucosal thickness utilizing ImageJ software
(https://imagej.nih.gov/ij/download.html) as previously described (10). The averaged measures
of mucosal thickness (arbitrary units using ImageJ) by individual were used in further analyses.
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3.3.5 Chicken DNA Isolation and Purification
Chicks were sampled for DNA on day 17 prior to viral challenge. Crude DNA lysates were
prepared by the method of Bailes et al. (11). Briefly, 10 µl of whole chicken blood was pipetted
from a 28-gauge lancet puncture of a wing vein and triturated into 400 µl of cold 64 mM
Sucrose, 20 mM TrisCl pH 7.5, 10 mM MgCl2, 0.5% Triton X-100 in a 96 well assay block on
ice. After all samples were collected, the block was sealed with a silicone mat lid, inverted
several times, then centrifuged at 1000  g for 5 minutes. The plate was inverted to decant off
the supernate. The nuclear pellets were suspended by trituration into TEN+Pronase (10 mM TrisCl pH 8.0, 1 mM EDTA, 10 mM NaCl, 100 μg/ml Pronase E; Sigma-Aldrich, St. Louis, MO).
The sealed block was incubated at 37oC for 60 minutes while shaking at an approximate 45degree angle, then incubated in a 65oC water bath for 15 minutes. Assay blocks were stored at 20oC in a non-frost-free freezer. Crude DNA samples from birds selected for high and low viral
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load phenotypic groups were identified. For these samples, 100 µl of the crude DNA lysate was
mixed with 100 µl TEN+Pronase, then incubated at 37oC for 60 min with shaking at an
approximate 45-degree angle. The block was then incubated at 65oC in a water bath for 10 min.
A stack of assay blocks and filter plates was prepared for centrifugal filtration consisting of a
1.2 µm filter plate (Pall #8040, Pall Corporation, Westborough, MA) on top of a 100 MWCO
filter plate (Pall #8036), on top of a 0.5 ml assay block to collect the final flow through. The
pronase-treated, heat-inactivated DNA solutions were pipetted into the corresponding wells. The
stack was centrifuged at 1500  g for 10 min (or longer until the upper wells were empty) at 5oC.
Te (200 µl; 10 mM TrisCl pH 7.5, 0.1 mM EDTA) was added to each well in the top plate, and
the stack centrifuged as above. The Te rinse was performed two times. The 1.2 µm plate was
discarded and 100 µl Te was added to the wells of the 100 MWCO filter plate sitting on the
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emptied waste collection block. The 100 MWCO filter plate was covered and the stack placed on
a platform orbital shaker at 500 rpm for 10 minutes at room temperature. The suspended DNA
was transferred to a 96-well raised-lip PCR plate. DNAs were quantified by Hoechst 33258
fluorescence using a GloMax Jr (Promega Corp. Madison, WI). The PCR plate was sealed with
silicone mat lid and stored frozen at -20oC.
3.3.6 Sequence Analysis for Identification of Gene Regions
Barcoded libraries from each DNA (50-200 ng) were produced using the RIPTIDE kit
(iGenomX, Carlsbad, CA). Pooled libraries were fractionated for insert size of ~375 bp. Pooled
libraries were submitted to NovoGene (Davis, CA) for QC and sequenced in one lane on an
Illumina NovaSeq. Sequence data was demultiplexed using FGBio (v 0.8.1). Reads for each
library were mapped onto the bGalgal1 (GRCg7b; maternal broiler) using Bowtie2 v2.4.4 (12)
and converted to indexed bam files using SAMtools v1.14 (13). We used two groupings of bam
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files for analyses: Method 1) bam files were randomly grouped into one of two pools 24
susceptible and 24 resistant, or Method 2) all 96 bam files were analyzed as one pool of 48
susceptible and 48 resistant. Each pool was then merged and filtered in a single vcf (variant call
file) using NGSEP (14). Filtering in NGSEP included: a) only biallelic SNPs, b) minimum
mapping quality ≥20, c) exclude SNPs in 3’ 3 bases, d) minimum genotype Qscore: 20, e)
maximum alignments per start position: 2, f) minimum read depth for genotype call: 4, and g)
minimum Minor Allele Frequency (MAF): 0.05. Filtering for Method 1 was for a minimum of
20 genotypes per position, while for Method 2 filtering was for a minimum of 40 genotype calls
per position. We also employed a control, Method A, for filtering for the 2-pool analysis in
Method 1. Method A allowed a maximum alignment per start position of 5 (filter setting e)
which is more tolerant of PCR duplications in library construction and amplification.

79

The final vcf was processed with SNPtest v2.5.4-beta3 (15), to impute genotype calls and
calculate Minor Allele Frequencies (MAF). Differences in MAF for Control (High)-Case (Low)
for each filtered biallelic SNPs were then visualized in Integrative Genomics Viewer (IGV) (16)
to identify regions where clusters of hundreds to thousands of successive SNPs show a skewed
difference in frequencies with respect to phenotype. MAF). For Method 2, SNPtest was also used
to calculate P-values using models of association for Additive, Dominant, Recessive, General, or
Heterozygote.
3.4 Results
Five days after inoculation, most chickens exhibited typical IB respiratory signs varying from
unapparent, mild, moderate, to severe. Consistent with this observation, viral loads varied from
almost undetectable to considerably high amounts of viral RNA in the trachea of individual
chickens. The median tracheal viral load for the females was 1835 (log10 relative IBV RNA);
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details on pathology and viral load have been published elsewhere (17). We selected the 48
females with the lowest IBV tracheal RNA to represent the low group ranging from 0.196 to
404.0 with a mean of 180.7 and standard error of 18.57. Conversely, the high group had viral
loads ranging from 553,300 to 28,390,000 with a mean of 918,851 and standard error of 70,211.
As seen in Figure 1A, there was a significant difference (P < 0.0001) between the high and low
group of females. The histomorphometry analysis of tracheal mucosal thickness of each of 48
individual chickens in the high and low groups is shown in Figure 1B. The mucosal thickness of
each individual bird was consistent with the viral loads, i.e., increased mucosal thickness in
chickens with higher viral load. Indeed, the 48 females showing high viral RNA showed
significantly higher mucosal thickness (P = 0.0004) than the 48 females showing the lowest IBV
RNA levels.
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DNAs from each of the 48 birds from the high and the low group were processed to produce
individually barcoded NGS libraries, which were pooled and sequenced on a single lane of an
Illumina NovaSeq. The demultiplexed reads yielded a range of 2.0-8.2 Gb per DNA with an
average of 7.56±0.44 (SEM). Reads were aligned to the most recent broiler assembly bGalgal1
(GRCg7b; maternal broiler) rather than the paternal layer because the broiler assembly is female
and contains marginally more assembled bases; 6.5 Mbp for the autosomes and chromosome Z.
The pipeline we employed using Bowtie2, together with SAMtools, has been found to be as
effective as other aligner-caller combinations for identification of SNPs when filtering (we used
NGSEP) is employed (18). We used three alternative methods to process the reads during the
alignment (described in Methods section). Method A tolerates PCR duplicates from the library
production while Methods 1 and 2 filter for reduction of duplicates. Method A and Method 1
processed the reads from each of the phenotype groups in pools of 24, which allowed replicate
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comparisons of MAF from the SNP genotype calls between pools from each phenotype group
(i.e., two comparisons of 24 high vs 24 low). For Method 2, the comparison was between all 48
low vs all 48 high.
We identified 16 regions using Method A which tolerates significant numbers of PCR
duplications. Restricting the level of PCR duplication in Method 1 reduced the number of
regions identified from 16 to 13. Significantly, none of the regions from Method A were present
in those from Method 1. When we combined all the data with reduction of PCR duplicates in
Method 2, the number of regions identified decreased to 6, but most importantly, one of the
regions on chromosome 18 was retained between Method 1 and Method 2. We considered the
regions other than this one to be likely false positives. As the region on Gga18 from 2.850-2.867
Mbp was identified in Methods 1 and 2, this region is much more likely to be a QTL for IBV
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viral load. The region contains all or part of the genes for ARHGAP44 (Rho GTPase activating
protein 44) and CDRT1 (CMT1A duplicated region transcript 1). ARHGAP44 in humans is
predicted to be involved in modification of dendritic spine, negative regulation of Rac protein
signal transduction, and regulation of plasma membrane bounded cell projection organization in
leading edge membranes. It is expressed broadly and at high levels in the lung, colon and brain.
The CDRT1 homolog in humans is FBXW10B (F-box and WD repeat domain containing 10B),
one of many F-box containing protein-ubiquitin ligases. It is expressed in most tissues but at the
highest levels in testis. There is no indication in the databases for Online Mendelian Inheritance
in Man, or NCBI PheGenI, that would connect either ARHGAP44 or CDRT1 to viral infection
or viral load.
3.5 Discussion
We performed whole genome mapping of naïve chickens showing high and low

82
susceptibility to a challenge with a virulent Ark-type IBV. Measurements of viral load and
tracheal damage were used as continuous quantitative traits to analyze host resistance to IBV.
Possible variation in susceptibility to viral infection was minimized by using white leghorn
chickens, i.e., pure breed chickens instead of crossbred broiler lines, only females, and
challenging at the same age. Furthermore, the use of SPF chickens ensured absence of both
maternal IBV-specific antibodies and other avian pathogens that could alter the outcome of IBV
infection. Rigorous efforts were made to administer the exact same dose to all individuals during
challenge. Challenge was performed at 18 days of age to avoid suboptimal responses associated
with an immature immune system at an earlier age (19-21).
We employed three different methods to process/filter the SNP data from the WGR. There
was no filtering for PCR duplicates in Method A, while for Methods 1 and 2, we employed
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filters for PCR duplicates. For both Method A and Method 1, we compared 24 low to 24 high,
with two replicates of the comparison while Method 2 compared all 48 low to all 48 high. With
Method A, we identified 16 potential regions as associated with IBV load, while with Method 1
there were 13 regions. Surprisingly, none of the regions were shared between the two methods.
To further test the significance of removal of PCR duplicates, WGR data from a commercial
broiler breeder male line, phenotyped for susceptibility to a bacterial chondronecrosis
osteomyelitis (BCO) challenge, was analyzed using Method A and Method 1. The WGR data
consisted of 24 susceptible and 24 resistant to a challenge with a BCO isolate (22). Method A
identified 12 regions, while Method 1 identified 27, but the two methods shared 5 regions,
whereas the same manipulation of the pipeline for IBV WGR changed all regions. This suggests
that there are no major regions affecting IB resistance and the regions mapped are all false
positives. To further examine this, Method 2 was performed where the data from all 48 low and
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all 48 high were compared and the number of samples was sufficient to compute P-values with
SNPtest according to alternative genetic models. Method 2 identified 6 regions with no regions
shared with Method A and one region shared with Method 1. Thus, the region on chromosome
18 from 2.850 to 2.865 Mbp may be relevant to reduced viral load. However, of the two genes
with coding sequences in this region, ARHGAP44 and CDRT1, only one appears to function in
pathways relevant to immune function or viral pathogenesis. ARHGAP44 is associated with
cytoskeletal functions related to retroviral release (23) and modulates immunocytolysis by
Natural Killer cells during carcinogenesis (24).
3.6 Conclusions
Overall, the WGR analyses are most consistent with little genetic basis for the wide variation
in IB viral load, since the analysis pipelines we used resulted in only one region shared between
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two of the methods. This is in contrast with WGR in ascites and BCO. The lack of genetic
diversity could be from the use of SPF leghorns, pure breed chickens. In which case, WGR in
commercial layers or broilers, which are out-crosses, would present higher genetic diversity.
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3.7 Tables and Figures
Table 3-1. Regions mapped for IBV phenotype based on the three pipelines. For each region the
chromosome (Chr) and approximate Start (Mbp), End (Mbp) and size (kbp) of the region. The
Method in which the region was identified, the Magnitude of the affect (MAF Control-Case), the
approximate maximum -logP for Method 2, and the genetic Models with significant P values
(Additive, Dominant, Recessive, Heterozygous).
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Chr Start
End
Size Method Magnitude -logP Model ADRH
1
41.1
42.8 1700
A
-0.3444
1
55.2
55.3 100
1
-0.429
1
74.36
75 640
1
0.429
1
78.45 78.52
70
1
-0.338
1
99.53 99.57
40
2
0.3
3
ADRH
1 130.73 130.84 110
1
-0.344
1
147.4 148.1 700
A
-0.4286
1 153.45 153.5
50
1
-0.375
2
82.7 82.77
70
A
-0.2167
2
122.9 123.3 400
A
0.375
2
139.8 139.9 100
A
-0.2857
2 149.02 149.6 580
2
0.25
4
H
3
34.28 34.44 160
A
0.35
3
57.6
58.2 600
A
0.4375
3
70.63 70.67
40
A
-0.2738
3
72.8
72.9 100
A
-0.3333
4
76.93 77.09 160
1
0.4375
5
11.9 12.03 130
1
-0.423
6
3.16
3.26 100
A
0.4375
8
27.12
27.2
80
A
0.2738
8
28.88 29.08 200
A
-0.3571
9
7.68
7.74
60
A
-0.3571
10
18.26 18.46 200
1
-0.215
11
18.65
18.9 250
A
0.3333
12
0.647 0.729
82
1
-0.222
12
1.35
1.55 200
2
-0.25
3.5
ADR
13
1
1.14 140
2
0.3
3.5
ADRH
13
17.45 17.65 200
A
-0.375
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Chr Start
End
Size Method Magnitude -logP Model ADRH
15
6.928
6.95
22
2
0
3.8
H
18
2.85 2.865
15
1
0.3
18
2.82 2.865
45
2
0.25
4.2
ARH
20
5.75
5.86 110
1
-0.26
23
3.04
3.06
20
1
0.214
25
1.15
1.19
40
A
-0.2286
20
5.6
5.95 350
1
-0.23
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Figure 3-1 Viral load (IBV RNA by qRT-PCR) in the trachea and tracheal mucosal thickness in
female SPF chickens 5 days after challenge with 104 EID50 of a virulent Ark-type IBV at 18
days of age. (A) Forty-six chickens with highest and lowest viral loads (log-transformed relative
IBV RNA). (B) Mucosal thickness of chickens included in the higher and lower viral load
groups. Boxes: 25th percentile, median, 75th percentile; whiskers: minimum and maximum).
Significant differences determined by t-test at P < 0.05.
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Figure 3-2 Integrative Genome Viewer for the region identified on chromosome 18. Left panel
is the view of the entire chromosome and the right panel is zoomed in on the region around 2.8
Mbp. Blue plots are for the MAF and red plots are for the -logP values for the genetic models for
Method 2.
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CHAPTER 4: CONCLUSIONS
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Chicken is a crucial source of dietary animal protein for humans. With a global population
that continues growing, there is increasing need for efficient and stable production of chicken
products. One of the ways chicken production could be hindered or compromised is through
disease which decreases supply and increases cost to the consumer.
Genetic progress toward highly efficient growth in broilers has been the pursuit of poultry
geneticists for more than 60 years of breeding. In that span of time, broilers have seen a 400%
increase in growth rate (1). While these changes have been an overall benefit to the industry,
there have also been negative consequences of this selection, as well. Some critical issues
include skeletal insufficiencies leading to lameness such as tibial dyschondroplasia and
spondylolisthesis (commonly known as “kinky back”), greater fat deposition, Sudden Death
Syndrome, and a decrease in meat quality characterized by myopathies such as woody breast,
white striping, and spaghetti meat (2-5). Metabolic disorders have also risen with genetic
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improvement, one of which is ascites. Ascites is the terminal outcome of prolonged pulmonary
hypertension, identifiable by the fluid-filled body cavity of afflicted birds (6). Ascites accounts
for at least 8% of bird mortality and up to $100 million in economic losses making it a concern
of both animal welfare and industry economic impact (7, 8).
While ascites represents an internal threat caused by increased growth efficiency in an
individual animal, infectious bronchitis virus (IBV) represents an external threat to the health of
the bird and the flock. Infectious bronchitis (IB), the illness caused by IBV, is a respiratory
gamma-coronavirus with similarities to SARS-CoV-2 (9-11). IBV ranks as the second most
problematic disease in poultry and is difficult to prevent due to the extensive number of distinct
strains, environmental factors, and the variation in immune response from flock to flock (12, 13).
Typically, birds are vaccinated with a viral vaccine cocktail to protect from variants that are
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specific to that area, although with variable efficacy (14). An improved prevention method for
this illness is severely needed to reduce its impact on bird morbidity and mortality as well as the
economic impacts of such a problematic virus.
Whole genome resequencing (WGR) has allowed for new insights into the genetic
determinants contributing to phenotypic variation. This bioinformatic analysis enables the
assessment of genetic variation in the genome associated with a given disease by identifying
single nucleotide polymorphisms (SNPs) that are differentially represented between the resistant
and susceptible phenotypes. Given the importance of maintaining a supply of chicken products to
meet the demand from the ever-growing global population and the threat of various avian
diseases that could diminish that supply, this body of work applied WGR to ascites and IBV.
The project described in Chapter 2 is the culmination of WGR completed previously at the
University of Arkansas. That work revealed two chromosomal regions, LRRTM4 and CPQ,
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contributing to genetic resistance to ascites in some chicken lines to the development of ascites.
Resistance to ascites in hypobaric challenges was associated with homozygous non-reference
SNPs in these two epistatic regions (15, 16). In order to demonstrate the efficacy and accuracy of
the WGR mapping, we conducted a marker-assisted selection (MAS) project where the SNPs in
those regions were driven to non-reference homozygosity over two generations of selection. In
theory, this would produce a population of birds with a greater innate resistance to the
development of ascites when presented with a metabolic stressor such as a hypobaric challenge.
The concern for industry geneticists about selection for ascites resistance is that birds
phenotypically selected to be more resistant also tend to have lower body weight (17, 18). This
has long been observed in the study of ascites and was also a result found by Pavlidis et al. (19)
when establishing the ascites susceptible and resistant research lines at the University of
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Arkansas. The susceptible line showed decreasing body weight at market age after each
successive generation of selection for ascites resistance. Therefore, the MAS project also
required assessment of the impact of selection on broiler growth characteristics. The overarching question was whether these regions would degrade highly efficient growth if they were
integrated into an industry breeding scheme.
Two cohorts each were raised under the conditions of a hypobaric challenge to assess ascites
phenotype or under standard broiler rearing practices to assess the impact on broiler growth
characteristics. The hypobaric challenge cohorts (Hypo1 and Hypo2) were subjected to a
simulated elevation of 9,000 feet and 11,000 feet, respectively. This change between cohorts was
made in order to increase ascites incidence in the second cohort and assess the impact of
selection under more severe metabolic stress. The two cohorts both saw at least a numerical
reduction in ascites incidence in the MAS genetic line compared to the control line with the
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reduction being significant (P=0.041) in Hypo1. The floor trial cohorts reared under broilerstandard practices were treated as biological replicates. The results of the floor trials showed no
significant impacts in the MAS line to any growth characteristic, processing measurement, organ
weight, or meat quality metric. In fact, significant improvements were seen in the MAS line in
several production traits. Overall, this project demonstrates the feasibility of utilizing identified
genetic markers in modern broiler-breeding selection schemes in the industry, reducing the
incidence of ascites while maintaining the more than 50 years of breeding progress.
Chapter 3 presented a new WGR project focused on identifying regions associated with
resistance or susceptibility to severe IBV response phenotype in white leghorn chickens.
Challenge of the birds with an Arkansas-type virulent strain of IBV allowed for the identification
of the birds with the 48 highest viral loads and the 48 lowest viral loads. The DNAs collected
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from those birds were then purified using a new method, separately barcoded, and the pooled
libraries sequenced. The Illumina data was analyzed through three alternative WGR pipelines,
denoted as Methods A, 1, and 2. Methods 1 and 2 are updated versions of Method A. The
outcome of the Method 1 and 2 analyses pinpointed a single region identified using both
methods. The regions found using Method A and the remaining regions found using Methods 1
and 2 are assumed to be false positives. The one region identified in multiple analyses, located
on chromosome 18 between 2.850-2.867 Mbp, included two genes: ARHGAP44 and CDRT1.
ARHGAP44 appears to be the more promising of the two, as it has documented involvement
with the release of retroviruses and with a molecule preventing the destruction of tumor cells by
Natural Killer cells (20, 21).
Taken together, this body of work expands upon the usefulness of WGR as a tool that can be
used to help reduce the incidence of diseases in poultry. By successfully identifying regions with
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strong associations to disease phenotype, WGR results can then be integrated into breeding and
genetic selection schemes, providing geneticists with the ability to reduce disease incidence
through the increase of innate resistance in their populations.
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